<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-13-00821</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1003455</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational biology</subject><subj-group><subject>Signaling networks</subject><subject>Systems biology</subject></subj-group></subj-group><subj-group><subject>Molecular cell biology</subject><subj-group><subject>Signal transduction</subject><subj-group><subject>Signaling in cellular processes</subject><subj-group><subject>Ras signaling</subject><subject>STAT signaling family</subject></subj-group></subj-group><subj-group><subject>Signaling in selected disciplines</subject><subj-group><subject>Oncogenic signaling</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Systems biology</subject></subj-group><subj-group><subject>Theoretical biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Mathematics</subject><subj-group><subject>Applied mathematics</subject><subj-group><subject>Complex systems</subject></subj-group></subj-group><subj-group><subject>Nonlinear dynamics</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>A Model for the Epigenetic Switch Linking Inflammation to Cell Transformation: Deterministic and Stochastic Approaches</article-title>
<alt-title alt-title-type="running-head">Cell Transformation Driven by an Epigenetic Switch</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gérard</surname><given-names>Claude</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gonze</surname><given-names>Didier</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lemaigre</surname><given-names>Frédéric</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Novák</surname><given-names>Béla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Oxford Centre for Integrative Systems Biology, Department of Biochemistry, University of Oxford, Oxford, United Kingdom</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>de Duve Institute, Université Catholique de Louvain (UCL), Brussels, Belgium</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Faculté des Sciences, Université Libre de Bruxelles (ULB), Campus Plaine, Brussels, Belgium</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Hatzimanikatis</surname><given-names>Vassily</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>École Polytechnique Fédérale de Lausanne, Switzerland</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">claude.gerard@uclouvain.be</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: CG. Performed the experiments: CG. Analyzed the data: CG DG FL BN. Wrote the paper: CG DG FL BN.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>1</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>30</day><month>1</month><year>2014</year></pub-date>
<volume>10</volume>
<issue>1</issue>
<elocation-id>e1003455</elocation-id>
<history>
<date date-type="received"><day>11</day><month>5</month><year>2013</year></date>
<date date-type="accepted"><day>10</day><month>12</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Gérard et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Recently, a molecular pathway linking inflammation to cell transformation has been discovered. This molecular pathway rests on a positive inflammatory feedback loop between NF-κB, Lin28, Let-7 microRNA and IL6, which leads to an epigenetic switch allowing cell transformation. A transient activation of an inflammatory signal, mediated by the oncoprotein Src, activates NF-κB, which elicits the expression of Lin28. Lin28 decreases the expression of Let-7 microRNA, which results in higher level of IL6 than achieved directly by NF-κB. In turn, IL6 can promote NF-κB activation. Finally, IL6 also elicits the synthesis of STAT3, which is a crucial activator for cell transformation. Here, we propose a computational model to account for the dynamical behavior of this positive inflammatory feedback loop. By means of a deterministic model, we show that an irreversible bistable switch between a transformed and a non-transformed state of the cell is at the core of the dynamical behavior of the positive feedback loop linking inflammation to cell transformation. The model indicates that inhibitors (tumor suppressors) or activators (oncogenes) of this positive feedback loop regulate the occurrence of the epigenetic switch by modulating the threshold of inflammatory signal (Src) needed to promote cell transformation. Both stochastic simulations and deterministic simulations of a heterogeneous cell population suggest that random fluctuations (due to molecular noise or cell-to-cell variability) are able to trigger cell transformation. Moreover, the model predicts that oncogenes/tumor suppressors respectively decrease/increase the robustness of the non-transformed state of the cell towards random fluctuations. Finally, the model accounts for the potential effect of competing endogenous RNAs, ceRNAs, on the dynamics of the epigenetic switch. Depending on their microRNA targets, the model predicts that ceRNAs could act as oncogenes or tumor suppressors by regulating the occurrence of cell transformation.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>An increasing amount of evidence demonstrates a close relation between inflammation and cancer development, which reveals the importance of the tumor microenvironment for the development of cancers. Recently, a molecular pathway linking inflammation to cell transformation, which is a prerequisite to cancer development, has been discovered. This molecular pathway is based on a positive inflammatory feedback loop between NF-κB, Lin28, Let-7 microRNA and IL6, allowing the occurrence of an epigenetic switch leading to cell transformation. Here, we propose a computational model to account for the dynamics of this epigenetic switch. We show that an irreversible bistable switch is at the core of the dynamics of the system. The model further indicates that oncogenes (activators of the switch) and tumor suppressors (inhibitors of the switch) regulate the occurrence of cell transformation by modulating the threshold of inflammatory signal needed to induce the switch. Stochastic simulations of the model suggest that molecular fluctuations are able to trigger cell transformation, highlighting possible links between stochasticity and cancer development. Finally, the model predicts a crucial role of competing endogenous RNAs (ceRNAs) for the dynamics of the epigenetic switch and the occurrence of cell transformation.</p>
</abstract>
<funding-group><funding-statement>CG thanks the Foundation Philippe Wiener – Maurice Anspach for financial supports. The work in BN's group was supported by the European Community's Seventh Framework Programmes MitoSys (241548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="19"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>The characteristics of cancer rest on many biological capabilities acquired during the multistep of the development of tumors <xref ref-type="bibr" rid="pcbi.1003455-Hanahan1">[1]</xref>. These biological properties include sustaining proliferative signaling, evading growth suppressors, resisting cell death, allowing replicative immortality, promoting angiogenesis, and eliciting formation of metastasis <xref ref-type="bibr" rid="pcbi.1003455-Hanahan1">[1]</xref>. The progression from normal cells to cancer could be strongly influenced by the tumor microenvironment. In that context, many studies have shown close relations between inflammation and different types of cancer <xref ref-type="bibr" rid="pcbi.1003455-Chiba1">[2]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Martin1">[4]</xref>. Inflammatory molecules, such as the interleukin-6 (IL6) or the transcription factor NF-κB, could provide growth signals, which elicit the proliferation of malignant cells <xref ref-type="bibr" rid="pcbi.1003455-Balkwill1">[5]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Balkwill2">[6]</xref>. However, until recently, the molecular regulatory network linking inflammation to cell transformation was poorly understood.</p>
<p>To study the molecular link between inflammation and cancer, Iliopoulos and coworkers used an experimental model of oncogenesis, which involves a derivative of MCF10A, a spontaneous immortalized cell line derived from normal mammary epithelial cells containing ER-Src, a fusion of the oncoprotein Src with the ligand binding domain of estrogen receptor <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. They demonstrated that transient treatment with tamoxifen results in stable cell transformation, defined by their invasive capabilities, their increased motility, as well as their ability to form mammospheres (multicellular structure enriched in cancer stem cells). This stable cell transformation can be defined as an epigenetic switch, which corresponds to a stable cell change to another phenotype without any change in DNA sequence. The triggering event of the epigenetic switch is mediated by a transient inflammatory signal driven by the Src oncoprotein <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. After the triggering event, the transformed state of the cell mediated by the epigenetic switch is stable for many generations. A positive inflammatory feedback loop driven by the transcription factor NF-κB, the microRNA binding protein Lin28, the Let-7 microRNA, and IL6 is responsible for the maintenance of this transformed state <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>.</p>
<p>Besides the critical role of microRNAs in the regulation of protein expression <xref ref-type="bibr" rid="pcbi.1003455-Carthew1">[8]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Selbach1">[10]</xref> or in conferring robustness of biological processes <xref ref-type="bibr" rid="pcbi.1003455-Tsang1">[11]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Ebert1">[14]</xref>; microRNAs, such as miR-122, are at the core of molecular regulatory feedback loop driving hepatocyte differentiation <xref ref-type="bibr" rid="pcbi.1003455-Laudadio1">[15]</xref>, or microRNAs, such as Let-7 microRNA family, are critical regulators in cancer development and progression <xref ref-type="bibr" rid="pcbi.1003455-Barh1">[16]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Ventura1">[19]</xref>. The positive inflammatory feedback loop discovered by Iliopoulos and coworkers brings to light the importance of microRNAs in the molecular regulatory circuit linking inflammation to cell transformation <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>.</p>
<p>Other studies showed that epigenetic regulations could play critical role in cancer <xref ref-type="bibr" rid="pcbi.1003455-Mathews1">[21]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Vincent1">[24]</xref>, and open novel perspectives in understanding developmental processes and diseases <xref ref-type="bibr" rid="pcbi.1003455-Goldberg1">[25]</xref>.</p>
<p>Here, we propose a computational model of a large network involving kinases, transcription factors, messenger RNAs and miRNAs to account for the qualitative dynamics of the epigenetic switch linking inflammation to cell transformation <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. By means of a deterministic model for the epigenetic switch, we will study the dynamical nature of the positive inflammatory feedback loop leading to cell transformation. We will see how tumor suppressors (inhibitors of this positive feedback loop) or oncogenes (activators of the inflammatory feedback loop) regulate the occurrence of cell transformation. By resorting to stochastic simulations as well as deterministic simulations in a heterogeneous cell population, we will assess the role of random fluctuations (resulting from molecular noise or from cell-to-cell variability) on the dynamics of the epigenetic switch. Furthermore, based on recent experiments describing the potential crucial role of competing endogenous RNA (ceRNA) as microRNA sponge on the control of molecular regulatory network <xref ref-type="bibr" rid="pcbi.1003455-Poliseno1">[26]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Poliseno2">[29]</xref>, we will study the effect of ceRNAs on the dynamical behavior of the model for the epigenetic switch linking inflammation to cell transformation.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Model for the epigenetic switch linking inflammation to cell transformation</title>
<p>We propose a computational model for the epigenetic switch linking inflammation to cell transformation (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref> as well as <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>). The model is based on a positive inflammatory feedback loop between NF-κB, Lin28, Let-7 microRNA and IL6. An inflammatory signal mediated by the oncoprotein Src activates NF-κB, which promotes the synthesis of Lin28. The microRNA-binding protein Lin28 rapidly reduces the synthesis of mature Let-7 microRNA, which ensures a higher production of IL6 than achieved directly by NF-κB. In turn, IL6 triggers the activation of NF-κB and promotes the synthesis of the transcription factor STAT3, whose activity is crucial to induce cell transformation <xref ref-type="bibr" rid="pcbi.1003455-Gao1">[30]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Bromberg1">[35]</xref>. As shown by Iliopoulos and coworkers <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>, STAT3 is not only a downstream output of the inflammatory regulatory signal, but is part of the positive feedback loop linking inflammation to cancer. Indeed, STAT3 triggers the synthesis of miR-21 and miR-181b-1 microRNAs <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. For simplicity, we only consider miR-21 in the model (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>). The latter microRNA down-regulates the translation of the tumor suppressor PTEN, which is responsible for the inhibition of the activity of NF-κB (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref> as well as <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Garcia1">[36]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Guigon1">[37]</xref>). Furthermore, we also consider the positive feedback loop between NF-κB, Lin28, Let-7 and the oncoprotein Ras. Indeed, NF-κB activates the synthesis of Lin28, which inhibits the synthesis of Let-7. The down-regulation of Let-7 prevents it to repress the synthesis of Ras, which promotes the activation of NF-κB (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>).</p>
<fig id="pcbi-1003455-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g001</object-id><label>Figure 1</label><caption>
<title>Wiring diagram of the model for the epigenetic switch linking inflammation to cell transformation <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>.</title>
<p>The Src oncoprotein elicits an inflammatory response regulated by NF-κB, which activates the transcription of Lin28. The latter protein represses the synthesis of Let-7 microRNA, which prevents Let-7 from inhibiting the expression of IL6. Since IL6 activates NF-κB, this creates a positive feedback loop with a higher activation of IL6 than achieved by NF-κB alone (see mutual activation between NF-κB and IL6). Furthermore, two other positive feedback loops are considered in the model: (1) the oncogene Ras activates NF-κB, which directly promotes the synthesis of Lin28, resulting in an inhibition of the synthesis of Let-7. The down-regulation of Let-7 prevents it from inhibiting the translation of Ras. (2) NF-κB activates IL6, which promotes the transcription of STAT3. The latter transcription factor elicits the synthesis of miR-21, which inhibits the translation of the tumor suppressor PTEN. The down-regulation of PTEN prevents it from inhibiting NF-κB. For the sake of simplicity, we consider in the model that PTEN directly down-regulates the activity of NF-κB. Actually, PTEN down-regulates Akt, which activates NF-κB <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Garcia1">[36]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Guigon1">[37]</xref>. For clarity reasons, the inhibitory complexes between Let-7 microRNA and IL6 mRNA, between Let-7 and Ras mRNA, as well as between miR-21 microRNA and PTEN mRNA are not represented in this scheme. All variables included in the model together with their definition are listed in <xref ref-type="table" rid="pcbi-1003455-t001">Table 1</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g001" position="float" xlink:type="simple"/></fig>
<p>In healthy cells, negative feedback loops between NF-κB and IκB protein family control NF-κB oscillations and ensure the occurrence of a transient inflammatory response within the cell <xref ref-type="bibr" rid="pcbi.1003455-Hoffmann1">[38]</xref>–<xref ref-type="bibr" rid="pcbi.1003455-Basak1">[42]</xref>. However in the immortalized cell line <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, it seems that NF-κB is rapidly activated through I-κBα phosphorylation, but its activity remains elevated during all the cell transformation process. For that reason and in order to confine our model to the dynamics of the epigenetic switch, we do not consider negative feedback regulation between NF-κB and IκB.</p>
<p>The model proposed for the molecular mechanisms of the epigenetic switch, linking inflammation to a stable cell transformation, counts 14 kinetic equations describing the time evolution of the concentration of the different variables considered (see Section “<xref ref-type="sec" rid="s4">Methods</xref>” here below, as well as <xref ref-type="table" rid="pcbi-1003455-t001">Table 1</xref> for a definition of the different variables of the model).</p>
<table-wrap id="pcbi-1003455-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.t001</object-id><label>Table 1</label><caption>
<title>Variables of the model.</title>
</caption><alternatives><graphic id="pcbi-1003455-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"><underline>Symbol</underline></td>
<td align="left" rowspan="1" colspan="1"><underline>Definition</underline></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">NFKB</td>
<td align="left" rowspan="1" colspan="1">Transcription factor NF-κB</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lin28</td>
<td align="left" rowspan="1" colspan="1">MicroRNA binding protein Lin28</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Let7</td>
<td align="left" rowspan="1" colspan="1">MicroRNA family Let-7, which represses the synthesis of IL6 and Ras</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mIL6</td>
<td align="left" rowspan="1" colspan="1">Messenger RNA of IL6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mIL6Let7</td>
<td align="left" rowspan="1" colspan="1">Complex form between mIL6 and Let7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">IL6</td>
<td align="left" rowspan="1" colspan="1">Interleukin 6 protein, which promotes the epigenetic switch leading to cell transformation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mRas</td>
<td align="left" rowspan="1" colspan="1">Messenger RNA of Ras oncogene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mRasLet7</td>
<td align="left" rowspan="1" colspan="1">Complex form between mRas and Let7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ras</td>
<td align="left" rowspan="1" colspan="1">Protein form of Ras oncogene</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">STAT3</td>
<td align="left" rowspan="1" colspan="1">Transcription factor STAT3, whose activity is crucial to promote cell transformation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miR21</td>
<td align="left" rowspan="1" colspan="1">MicroRNA miR21, which represses the translation of the tumor suppressor PTEN</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mPTEN</td>
<td align="left" rowspan="1" colspan="1">Messenger RNA of the tumor suppressor PTEN</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miRmpten</td>
<td align="left" rowspan="1" colspan="1">Complex form between miR21 and mPTEN</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">PTEN</td>
<td align="left" rowspan="1" colspan="1">Protein form of the tumor suppressor PTEN (phosphatase and tensin homologue)</td>
</tr>
<tr>
<td colspan="2" align="left" rowspan="1"><bold>Addition of a competing endogenous RNA (ceRNA), which binds to Let-7 microRNA</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ceRNA</td>
<td align="left" rowspan="1" colspan="1">Competing endogenous RNA, which can bind to Let7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ceRNAlet7</td>
<td align="left" rowspan="1" colspan="1">Complex between ceRNA and Let7</td>
</tr>
<tr>
<td colspan="2" align="left" rowspan="1"><bold>Addition of PTEN1 mRNA, which binds to the microRNA miR-21</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">mPTEN1</td>
<td align="left" rowspan="1" colspan="1">Messenger RNA of PTEN1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">miRmpten1</td>
<td align="left" rowspan="1" colspan="1">Complex between mPTEN1 and miR21</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap>
<p>As observed in the experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, a transient inflammatory signal mediated by Src is sufficient to trigger the switch from an immortalized cell line to a stable transformed state (see <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2</xref>). Time evolution of Let-7, Lin28, IL6, NF-κB and STAT3 is shown in the absence of Src (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2A</xref>), in the presence of a constant, low level of Src (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2B</xref>), in the presence of higher level of Src for only 5 min (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2C</xref>), or in the presence of a constant higher level of Src (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2D</xref>). In the absence of Src, a high level of Let-7 together with low levels of Lin28, IL6, NF-κB and STAT3 are observed (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2A</xref>). We define those expression levels as a normal, non-transformed state of the cell. However, with a constant level of Src (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2B, D</xref>) or with a transient level of Src for only 5 min (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2C</xref>), the model exhibits a switch-like behavior in the expression levels of Let-7, Lin28, IL6, NF-κB and STAT3. Indeed, the level of Let-7 is reduced while levels of Lin28, IL6, NF-κB and STAT3 are highly increased at about t = 35 h (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2B</xref>), t = 65 h (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2C</xref>), and t = 10 h (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2D</xref>). In the model, we define this switch as the passage to cell transformation. As in the experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, the model shows that cell transformation can occur with an inflammatory signal of only 5 min. In the latter case, the occurrence of cell transformation is slow, and happens at t = 65 h instead of t = 36 h with a constant level of Src (compare <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2B and 2C</xref> as well as <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>). The model is characterized by a biphasic regulation of the different variables. For instance, we can observe a first slow increase of IL6 followed by a boost of IL6 expression. This dynamical behavior may correspond to the experimental observation showing also a biphasic regulation of IL6 expression <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>.</p>
<fig id="pcbi-1003455-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g002</object-id><label>Figure 2</label><caption>
<title>Activation of the epigenetic switch by the Src oncoprotein.</title>
<p>Time evolution of NF-κB, Lin28, Let-7, IL6 and STAT3 in the absence of Src in A; in the presence of a constant, low level of Src (Src = 0.00005) in B; in the presence of a transient, higher level of Src (Src = 0.015 during 5 min from t = 0) in C; and in the presence of a constant, higher level of Src (Src = 0.015) in D. (A) The absence of Src prevents the occurrence of an inflammatory response. Let-7 is present at a high level, while low levels of NF-κB, Lin28, IL6 and STAT3 are observed. (B) The presence of Src generates an inflammatory response: a switch leading to cell transformation characterized by a low level of Let-7 together with high levels of NF-κB, Lin28, IL6 and STAT3 occurs at t = 36 h. (C) 5 min of Src activation is sufficient to turn on the switch after t = 60 h. These time scales correspond to those observed in the experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. (D) The model predicts that, with a constant high level of Src, the switch occurs earlier. Parameter values used in the simulations are given in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref>. Values for the initial conditions used can be found in the Section: “<xref ref-type="sec" rid="s4">Methods</xref>”.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g002" position="float" xlink:type="simple"/></fig>
<p>Furthermore, the model also accounts for the experimental observations showing that the positive feedback loop involving NF-κB, Lin28, Let-7, and IL6 is required for maintenance of the transformed state of the cell <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. Indeed, from a stable transformed state, a transient inhibition of either NF-κB, Lin28, or IL6 (as in the experiments) abolishes the transformed state and brings back the normal, non-transformed state of the cell (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s001">Fig. S1</xref>).</p>
</sec><sec id="s2b">
<title>Effect of the tumor suppressors, Let-7 &amp; PTEN, on the dynamics of cell transformation</title>
<p>Let-7 microRNA and PTEN are tumor suppressors and negative regulators of the epigenetic switch leading to cell transformation (see <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref> as well as <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>). By resorting to the computational model, we can assess the role of these tumor suppressors on the dynamics of the switch linking inflammation to cell transformation. To this end, we analyze the dynamical behavior of the model by means of bifurcation diagrams, which bring to light the steady-state levels of the system, i.e. equilibrium levels of the different variables of the model, as a function of a parameter value. In <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref>, the steady-state levels of NF-κB, Let-7, IL6 and STAT3 are shown as a function of the inflammatory signal, Src, for different rates of synthesis of Let-7, <italic>V</italic><sub>SLET7</sub>. The model indicates that the epigenetic switch linking inflammation to cell transformation behaves as an irreversible bistable switch towards the inflammatory signal, Src. Indeed, in the presence of low levels of Src, the model predicts that a non-transformed state defined by low levels of NF-κB, IL6 and STAT3 together with a high level of Let-7 coexists with a transformed state characterized by high levels of NF-κB, IL6 and STAT3 together with a low level of Let-7. Depending on the value of initial conditions, the system reaches the non-transformed or the transformed state. In the presence of high level of Src, only the transformed state remains.</p>
<fig id="pcbi-1003455-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g003</object-id><label>Figure 3</label><caption>
<title>Effect of Let-7 microRNA on the dynamical behavior of the epigenetic switch leading to cell transformation.</title>
<p>Bifurcation diagrams showing the steady-state levels of NF-κB, Let-7, IL6 and STAT3 as a function of the inflammatory signal, Src, are shown in panels A to D, respectively. For each case, different rates of synthesis of Let-7, <italic>V</italic><sub>SLET7</sub> are considered: <italic>V</italic><sub>SLET7</sub> is equal to 1, 3, 4, 6 and 8. Solid curves correspond to stable steady states, while dashed curves represent unstable states. A transformed state of the cell defined by high levels of NF-κB, IL6 and STAT3 together with a low level of Let-7 is present regardless of the level of Src when <italic>V</italic><sub>SLET7</sub> is small, <italic>V</italic><sub>SLET7</sub> = 1. For higher rates of synthesis of Let-7 (<italic>V</italic><sub>SLET7</sub> = 3, 4 and 6), the system is defined by an irreversible bistable switch characterized by the coexistence of low and high levels of the different variables for small values of Src, and by a low level of Let-7 and high levels of NF-κB, IL6 and STAT3 at high values of Src. An increase in <italic>V</italic><sub>SLET7</sub> from 3 to 6 moves the switch leading to an inflammatory response and cell transformation to higher levels of Src. When <italic>V</italic><sub>SLET7</sub> is elevated, <italic>V</italic><sub>SLET7</sub> = 8, the inflammatory response is very weak, regardless of the level of Src. Note that in the upper branch of the bistable switch, we cannot distinguish the different curves because their levels are very close to each other. Parameter values used in the simulations are given in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g003" position="float" xlink:type="simple"/></fig>
<p>The model suggests that Let-7 microRNA acts as a tumor suppressor because it moves the threshold leading to cell transformation to higher level of Src (see <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3A–D</xref> when <italic>V</italic><sub>SLET7</sub> increases from 3 to 8). The model also predicts that, when the rate of synthesis of Let-7 is too small, only the transformed state is present (see curves in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref> when <italic>V</italic><sub>SLET7</sub> = 1).</p>
<p>Steady-state levels of Let-7 and IL6 <italic>vs</italic> Src illustrated for different rates of transcription of PTEN, <italic>V</italic><sub>SMPTEN</sub>, indicate that the tumor suppressor PTEN exhibits a similar effect as Let-7 on the dynamics of the epigenetic switch leading to cell transformation (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s002">Fig. S2</xref>). Indeed, an increase in <italic>V</italic><sub>SMPTEN</sub> moves the threshold defining cell transformation to higher levels of Src.</p>
</sec><sec id="s2c">
<title>Effect of the oncogene Ras on the epigenetic switch leading to a transformed state</title>
<p>Contrary to Let-7 and PTEN, Ras is a positive regulator of the epigenetic switch leading to cell transformation (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref> as well as <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Shields1">[43]</xref>). Bifurcation diagrams of Let-7, IL6 and Ras <italic>vs</italic> Src are shown for different rates of transcription of Ras, <italic>V</italic><sub>SMRAS</sub> in <xref ref-type="fig" rid="pcbi-1003455-g004">Fig. 4A–C</xref>, respectively. In the framework of the epigenetic switch linking inflammation to cancer, the model indicates that Ras acts as an oncogene by moving the threshold leading to cell transformation to smaller levels of the inflammatory signal, Src (see <xref ref-type="fig" rid="pcbi-1003455-g004">Fig. 4</xref> when <italic>V</italic><sub>SMRAS</sub> increases from 0 to 0.027). For high level of Ras, i.e. <italic>V</italic><sub>SMRAS</sub> = 0.03, the model predicts that the cell is only present in a transformed state (low level of Let-7 together with high levels of IL6 and Ras) regardless of the level of Src.</p>
<fig id="pcbi-1003455-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g004</object-id><label>Figure 4</label><caption>
<title>Effect of the oncogene Ras on the dynamical behavior of the epigenetic switch.</title>
<p>Bifurcation diagrams showing the steady-state levels of Let-7, IL6 and Ras are shown respectively in panels A to C as a function of the inducer signal, Src. For each case, different rates of transcription of Ras, <italic>V</italic><sub>SMRAS</sub> are considered. <italic>V</italic><sub>SMRAS</sub> is equal to 0, 0.005, 0.02, 0.027 and 0.03. Solid curves: stable steady states; dashed curves: unstable states. A transformed state of the cell, defined by a low level of Let-7 and high levels of IL6 and Ras, is observed regardless of the level of Src when <italic>V</italic><sub>SMRAS</sub> is high (<italic>V</italic><sub>SMRAS</sub> = 0.03). For lower rates of transcription of Ras, the model predicts a bistable response as a function of Src. Starting from <italic>V</italic><sub>SMRAS</sub> = 0, an increase in <italic>V</italic><sub>SMRAS</sub> moves the threshold leading to cell transformation to smaller levels of the inflammatory signal, Src. Parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref>, with <italic>V</italic><sub>SLET7</sub> = 6.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s2d">
<title>Cell transformation driven by stochastic transitions</title>
<p>It has been shown in many biological systems that stochastic transitions may represent a driving force in development and in cell fate decisions <xref ref-type="bibr" rid="pcbi.1003455-Feinberg1">[44]</xref>. Here, by resorting to a stochastic version of the model for the epigenetic switch linking inflammation to cancer (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s011">Table S1</xref> in Supporting Information), we assess the effect of stochastic fluctuations on the dynamics of the epigenetic switch. Deterministic (<xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5A</xref>) and the corresponding stochastic time evolution (<xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5C, E</xref>) of NF-κB, Lin28, Let-7, IL6 and STAT3 indicate that while deterministic transition to a transformed state of the cell occurs at about t = 20 h (<xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5A</xref>), stochastic fluctuations may prevent the occurrence of such transition (compare <xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5C and 5E</xref>). The opposite is also observed: stochastic fluctuations driving the occurrence of cell transformation while the deterministic version of the model predicts a non-transformed state (compare <xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5B</xref> with <xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5D and 5F</xref>).</p>
<fig id="pcbi-1003455-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g005</object-id><label>Figure 5</label><caption>
<title>Effect of stochastic fluctuations on the epigenetic switch leading to cell transformation.</title>
<p>Deterministic (A and B) <italic>vs</italic> stochastic time evolution (C–F) of NF-κB, Lin28, Let-7, IL6 and STAT3. For the same conditions, as a result of stochastic fluctuations, the switch leading to cell transformation may or may not occur (compare the deterministic simulations in A with the corresponding stochastic simulations in C and E, as well as the deterministic time course in B with the corresponding stochastic time evolution in D and F). Stochastic simulations were performed by means of the Gillespie's algorithm <xref ref-type="bibr" rid="pcbi.1003455-Gillespie1">[63]</xref> using the stochastic version of the model for the epigenetic switch (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s011">Table S1</xref> in Supporting Information). The units on the axes for the stochastic curves are expressed in numbers of molecules. The corresponding concentrations for the deterministic trajectories are obtained by dividing the numbers of molecules by Ω expressed in units of 10<sup>6</sup> L/N<sub>A</sub>, where N<sub>A</sub> is Avogadro's number. Here, as well as in all stochastic simulations in this study, Ω = 100. Parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with Src = 0.000001 and <italic>V</italic><sub>SLET7</sub> = 3.5 in panels A, C, E; and with Src = 0.00001 and <italic>V</italic><sub>SLET7</sub> = 4 in panels B, D, F.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g005" position="float" xlink:type="simple"/></fig>
<p>Could the tumor suppressors, Let-7 microRNA and PTEN, or the oncogene Ras influence the occurrence of stochastic transitions in the model linking inflammation to cell transformation? To answer that question, we constructed deterministic as well as stochastic bifurcation diagrams of IL6 <italic>vs</italic> Src for different rates of synthesis of Let-7, PTEN, or Ras.</p>
<p>Deterministic bifurcation diagrams of IL6 <italic>vs</italic> Src are shown when the rate of synthesis of Let-7, <italic>V</italic><sub>SLET7</sub> is equal to 3, 3.5 and 4 in <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6A, C, E</xref>, respectively. The corresponding stochastic bifurcation diagrams are illustrated in <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6B, D, F</xref>, respectively. With the initial conditions used (see section: “<xref ref-type="sec" rid="s4">Methods</xref>”), deterministic simulations indicate that the cell is always in a transformed state when <italic>V</italic><sub>SLET7</sub> = 3 or 3.5 (red dots in <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6A, C</xref>); while, when <italic>V</italic><sub>SLET7</sub> = 4, the cell is in a non-transformed state for low levels of Src and in a transformed state for higher levels of Src (see red dots in <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6E</xref>). The corresponding stochastic simulations for the same conditions indicate that, for low levels of Src, the proportion of cells present in a non-transformed state is larger when <italic>V</italic><sub>SLET7</sub> increases (compare <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6B, D and F</xref>). Thus, the model indicates that high levels of Let-7 may enhance the robustness of the non-transformed state to stochastic fluctuations by reducing the occurrence of stochastic switches leading to cell transformation. The fact that the deterministic unstable steady state is closer to the stable steady state with a low level of IL6 (non-transformed state) when <italic>V</italic><sub>SLET7</sub> is small is already an indication that the latter stable steady state may be less robust to stochastic fluctuations in the presence of low levels of Let-7 (compare dashed curves in <xref ref-type="fig" rid="pcbi-1003455-g006">Fig. 6A, C, E</xref>).</p>
<fig id="pcbi-1003455-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g006</object-id><label>Figure 6</label><caption>
<title>Effect of Let-7 microRNA on the robustness of the epigenetic switch towards molecular noise.</title>
<p>(A, C, E) Deterministic simulations. The steady-state level of IL6 <italic>vs</italic> Src is represented for <italic>V</italic><sub>SLET7</sub> = 3 (A), 3.5 (C), and 4 (E). Red dots correspond to the steady state level of IL6 reached with the initial conditions used (see <xref ref-type="sec" rid="s4">Methods</xref>). Solid curves: stable steady states; dashed curves: unstable states. Stochastic simulations showing the proportion of transformed and non-transformed state of the cells <italic>vs</italic> Src are represented in panels B, D and F for the conditions of panels A, C, E, respectively. Transformed state is defined by high level of IL6 together with low level of Let-7, while low level of IL6 together with high level of Let-7 characterizes a non-transformed state (see also stochastic time series in <xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5</xref>). The proportion of transformed <italic>vs</italic> non-transformed state of the cells is estimated with 50 stochastic cells for each condition, after a transient time of 50 h. For low levels of Src, nearly all cells are present in a transformed state when <italic>V</italic><sub>SLET7</sub> = 3 (B); a mixed population of transformed and non-transformed cells is present when <italic>V</italic><sub>SLET7</sub> = 3.5 (D); while nearly all cells are present in a non-transformed state when <italic>V</italic><sub>SLET7</sub> = 4 (F). Parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g006" position="float" xlink:type="simple"/></fig>
<p>Similarly to Let-7 microRNA, the model shows that the tumor suppressor PTEN is also able to increase to robustness of the cell towards stochastic cell transformation (<xref ref-type="supplementary-material" rid="pcbi.1003455.s003">Fig. S3</xref>). Deterministic bifurcation diagrams of IL6 steady-state levels <italic>vs</italic> Src indicate that the stable steady state corresponding to a non-transformed state (low level of IL6) is larger when the rate of transcription of PTEN, <italic>V</italic><sub>SMPTEN</sub> is high (compare <xref ref-type="supplementary-material" rid="pcbi.1003455.s003">Fig. S3A</xref>, C). In the stochastic approach, the model shows that increasing the level of PTEN reduces the occurrence of cell transformation for low level of Src (compare <xref ref-type="supplementary-material" rid="pcbi.1003455.s003">Fig. S3B and S3D</xref>).</p>
<p>Deterministic and stochastic simulations performed for different rates of transcription of the oncogene Ras, <italic>V</italic><sub>SMRAS</sub> suggest that, contrary to Let-7 or PTEN, an elevated level of Ras increases the sensitivity of the switch to stochastic fluctuations for the occurrence of cell transformation (see <xref ref-type="fig" rid="pcbi-1003455-g007">Fig. 7</xref>). Indeed, deterministic bifurcation diagrams indicate that the stable steady state with a low level of IL6 (corresponding to a non-transformed state) gets smaller when <italic>V</italic><sub>SMRAS</sub> increases from 0.005 to 0.027 (see <xref ref-type="fig" rid="pcbi-1003455-g007">Fig. 7A, C, E</xref>). The corresponding stochastic simulations suggest that a robust switch without transformed cells, for low level of Src, is present when <italic>V</italic><sub>SMRAS</sub> is small (<xref ref-type="fig" rid="pcbi-1003455-g007">Fig. 7B</xref>). By increasing the level of Ras, the switch leading to cell transformation becomes less robust to stochastic fluctuations and a significant proportion of transformed cells appear even for a low level of inflammatory signal, Src (<xref ref-type="fig" rid="pcbi-1003455-g007">Fig. 7D, F</xref>).</p>
<fig id="pcbi-1003455-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g007</object-id><label>Figure 7</label><caption>
<title>Effect of Ras oncogene on the robustness of the switch towards stochastic fluctuations.</title>
<p>(A, C, E) Deterministic simulations. The steady-state level of IL6 <italic>vs</italic> Src is represented for <italic>V</italic><sub>SMRAS</sub> = 0.005 (A), 0.02 (C), and 0.027 (E). Red dots correspond to the steady state level of IL6 reached with the initial conditions considered (see <xref ref-type="sec" rid="s4">Methods</xref>). Solid curves: stable steady states; dashed curves: unstable states. Stochastic simulations showing the proportion of transformed and non-transformed cells <italic>vs</italic> Src for the conditions of panels A, C, E are shown in panels B, D and F, respectively. For low levels of Src, the robustness of the non-transformed state decreases when the rate of synthesis of the oncogene Ras, <italic>V</italic><sub>SMRAS</sub>, increases (compare panels B, D and F). Indeed, even with a low level of Src, the proportion of transformed cells increases when <italic>V</italic><sub>SMRAS</sub> is high. Parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref> with <italic>V</italic><sub>SLET7</sub> = 6.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g007" position="float" xlink:type="simple"/></fig>
<p>Besides ‘intrinsic noise’ coming from molecular noise (stochastic fluctuations), the dynamics of the inflammatory network may be also influenced by ‘extrinsic noise’ originating from to cell-to-cell variability in a population. In that framework, recent studies have shown that the dynamics of activation of NF-κB is heterogeneous within a cell population <xref ref-type="bibr" rid="pcbi.1003455-Ashall1">[40]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Tay2">[45]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Turner1">[46]</xref>. Those studies suggested that the dynamics of cell responding to inflammatory signaling is partly driven by stochastic processes, but seems mostly controlled by pre-existing variation in internal variables of the cells (extrinsic noise) <xref ref-type="bibr" rid="pcbi.1003455-Ashall1">[40]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Tay2">[45]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Turner1">[46]</xref>.</p>
<p>To address the issue of cell-to-cell heterogeneity on the dynamics of the network, we will study, in the next section, the dynamics of the epigenetic switch in a heterogeneous cell population.</p>
</sec><sec id="s2e">
<title>Transformed versus non-transformed state of the cells in a heterogeneous cell population</title>
<p>In order to see if this epigenetic switch is relevant for human cancers, Iliopoulos and coworkers examined the expression levels of IL6 and Let-7 in cancer and normal breast, prostate, hepatocellular, and lung tissues <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. They showed that cancer tissues have higher levels of IL6 and lower levels of Let-7 as compared to normal tissues. A negative correlation is also observed in the expression levels of Let-7 and IL6 for breast, prostate, and hepatocellular tissues <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>.</p>
<p>By resorting to the deterministic model proposed for the switch leading to cell transformation, we are able to reproduce qualitatively these experimental observations. To do so, we analyze the expression pattern of IL6 and Let-7 in a model for a heterogeneous cell population. For each cell in the population, which counts 100 cells, all the parameters values are chosen randomly with 10% of variation from their default value (see <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8</xref>).</p>
<fig id="pcbi-1003455-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g008</object-id><label>Figure 8</label><caption>
<title>Expression of Let-7 <italic>vs</italic> IL6 in a heterogeneous cell population.</title>
<p>Deterministic simulations are performed with 100 cells with 10% of random variation from the default value on each parameter of the model. Each dot corresponds to the state of one cell after 50 h of transient time. (A) Normal, non-transformed state of the cell population. Nearly all cells exhibit high levels of Let-7 and low levels of IL6. Parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref> with <italic>V</italic><sub>SLET7</sub> = 6. (B) From the condition in A, an increase in <italic>V</italic><sub>SMRAS</sub> from 0.005 to 0.02 generates a mixed population of transformed and non-transformed cells. (C) A further increase in <italic>V</italic><sub>SMRAS</sub> to 0.05 allows switching to a population of transformed cells (high levels of IL6 together with low levels of Let-7). From the condition in A, the switch of the cell population from a non-transformed to a transformed state can be also achieved by decreasing the rate of synthesis of Let-7, <italic>V</italic><sub>SLET7</sub> from 6 to 3 (D), or by increasing the rate of synthesis of the transcription factor Lin28, <italic>V</italic><sub>SLIN28</sub> from 0.012 to 0.024 (E). (F) From the condition in C, an increase in the transcription rate of PTEN, <italic>V</italic><sub>SMPTEN</sub> from 0 to 0.5 allows recovering a normal, non-transformed state of the cell population. In each case, the model exhibits a negative correlation between Let-7 and IL6 expression, as observed in the experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. Other default values of the parameters are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with Src = 0.000001.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g008" position="float" xlink:type="simple"/></fig>
<p>The model for the cell population shows that a normal, non-transformed state can be achieved with high levels of Let-7 together with low levels of IL6 (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8A</xref>). From that state, the model predicts that an increase in the level of the oncogene Ras triggers cell transformation in a significant proportion of cells in the population (see <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8B</xref>), which results in a mixed population of non-transformed and transformed cells. A further increase in Ras almost completely switches the cell population to a transformed state, defined by high levels of IL6 and low levels of Let-7 (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8C</xref>). The model indicates that by starting from a non-transformed state of the cell population (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8A</xref>), the switch of the cell population to a transformed state can be also triggered by reducing the rate of synthesis of Let-7, <italic>V</italic><sub>SLET7</sub> (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8D</xref>), or by increasing the level of Lin28 (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8E</xref>). Finally, the model predicts that a transformed state of the cell population (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8C</xref>) could switch back to a non-transformed state by increasing the level of the tumor suppressor PTEN (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8F</xref>). This latter result supports the experimental observations showing that elevated levels of PTEN induce a tumor-suppressive metabolic state <xref ref-type="bibr" rid="pcbi.1003455-GarciaCao1">[47]</xref>.</p>
<p>In all cases, the model indicates, as in the experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, that the expression pattern of Let-7 and IL6 is negatively correlated.</p>
<p>To assess the robustness of the model with respect to random variation of parameters in a heterogeneous cell population, we further illustrate the expression levels of Let-7 and IL6 in a heterogeneous cell population for increasing levels of random variation on parameters: 5%, 10%, 25% and 50% (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s004">Fig. S4</xref>). Simulations show that even with large random variation on every parameter of the model (25% or 50%), most cells in the population are characterized by a non-transformed state in normal conditions (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s004">Fig. S4G, S4J</xref>) as well as in the presence of high levels of both Ras and PTEN (<xref ref-type="supplementary-material" rid="pcbi.1003455.s004">Fig. S4I, S4L</xref>). In contrast, in each case, most cells in the population are defined by a transformed state in the presence of high levels of Ras (<xref ref-type="supplementary-material" rid="pcbi.1003455.s004">Fig. S4H, S4K</xref>). This result indicates that the model is quite robust to random variations on parameter values.</p>
<p>By resorting to the deterministic model for a heterogeneous cell population, we are also able to reproduce the dynamical behavior of NF-κB activation. Indeed, single-cell analysis revealed that the activation of NF-κB is heterogeneous and is a digital on-off process with fewer cells responding at lower doses of inflammatory signal <xref ref-type="bibr" rid="pcbi.1003455-Tay2">[45]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Turner1">[46]</xref>. The model accounts for this observation by showing that the expression levels of Let-7 and NF-κB are characterized by two main states: (1) high levels of Let-7 and low levels of NF-κB, or (2) low levels of Let-7 and high levels of NF-κB (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s005">Fig. S5</xref>). The number of responding cells, defined by high levels of NF-κB and low levels of Let-7 increases by increasing the level of inflammatory signal, Src (compare panels A to C in <xref ref-type="supplementary-material" rid="pcbi.1003455.s005">Fig. S5</xref>).</p>
</sec><sec id="s2f">
<title>miR-21 may trigger cell transformation</title>
<p>The microRNA miR-21 is overexpressed and promotes invasion in pancreatic ductal adenocarcinoma <xref ref-type="bibr" rid="pcbi.1003455-Giovannetti1">[48]</xref>. Moreover, it was shown experimentally that miR-21 is an activator in the regulatory feedback loop linking inflammation to cell transformation <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. Indeed, STAT3 promotes the expression of miR-21, which results in the down-regulation of the tumor suppressor PTEN leading to an activation of NF-κB (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>). A transient expression of miR-21 can induce the epigenetic switch, which leads to cell transformation and formation of mammospheres in mouse xenografts <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. The positive feedback loop between NF-κB, Lin28, Let-7, IL6 is crucial for this process of cellular transformation because the concomitant overexpression of miR-21 together with the inhibition of Lin28 considerably reduce cell transformation and mammospheres formation <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>.</p>
<p>In the model, from a non-transformed state of the cell characterized by a high level of Let-7 and low levels of NF-κB, Lin28, IL6, and STAT3, the overexpression of miR-21 triggers the switch to cell transformation, which results in a low level of Let-7 and high levels of NF-κB, Lin28, IL6, and STAT3 (see <xref ref-type="fig" rid="pcbi-1003455-g009">Fig. 9A</xref>). The model qualitatively reproduces the experimental observation by showing that the concomitant overexpression of miR-21 together with a partial inhibition of Lin28 is not able to trigger the switch to cell transformation (<xref ref-type="fig" rid="pcbi-1003455-g009">Fig. 9B</xref>). Indeed, only a small increase in the level of NF-κB, Lin28, IL6, and STAT3 and a small decrease in Let-7 are observed (see <xref ref-type="fig" rid="pcbi-1003455-g009">Fig. 9B</xref> for t&gt;100 h).</p>
<fig id="pcbi-1003455-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g009</object-id><label>Figure 9</label><caption>
<title>miR-21 microRNA acts as an oncogene promoting cell transformation.</title>
<p>Time evolution of NF-κB, Lin28, Let-7, IL6 and STAT3 is shown in the presence of an overexpression of miR-21 (panel A for t&gt;100 h), and in the presence of an overexpression of miR-21 together with an inhibition of Lin28 (panel B for t&gt;100 h). For t&lt;100 h, normal condition, non-transformed state of the cell characterized by a high level of Let-7 and low levels of Lin28, NF-κB, IL6 and STAT3. (A) The overexpression of miR-21, <italic>V</italic><sub>SMIR21</sub> = 4000, triggers cell transformation. (B) The same overexpression of miR-21 does not trigger cell transformation if Lin28 is inhibited, <italic>V</italic><sub>SLIN28</sub> = 0.008 instead of 0.012. Other parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref> with <italic>V</italic><sub>SLET7</sub> = 3, <italic>V</italic><sub>SMPTEN</sub> = 0.1, <italic>Src</italic> = 0.00001.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g009" position="float" xlink:type="simple"/></fig>
<p>Iliopoulos and coworkers also showed, in colon adenocarcinomas, a positive correlation in the expression pattern of miR-21 and STAT3 as well as a negative correlation in the expression pattern of miR-21 and PTEN <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. By resorting to the deterministic model for a heterogeneous cell population, we can reproduce qualitatively these expression patterns (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s006">Fig. S6</xref>). A low rate of synthesis of miR-21 generates a mixed population of non-transformed and transformed cells (<xref ref-type="supplementary-material" rid="pcbi.1003455.s006">Fig. S6A</xref>, B). From that condition, an increase in the rate of synthesis of miR-21 switches the cell population to a transformed state characterized by high levels of miR-21 and STAT3 together with low levels of PTEN (<xref ref-type="supplementary-material" rid="pcbi.1003455.s006">Fig. S6C</xref>, D). From the latter condition, a reduction in the level of Lin28 brings back a large proportion of cells to a non-transformed state defined by low levels of miR-21 and STAT3 together with high levels of PTEN (<xref ref-type="supplementary-material" rid="pcbi.1003455.s006">Fig. S6E</xref>, F). This result supports the experimental observations showing the reduced number of mammospheres formation in the presence of Lin28 inhibition <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>.</p>
</sec><sec id="s2g">
<title>Control of cell transformation by competing endogenous RNA, ceRNA</title>
<p>Recent hypothesis suggests that some messenger RNAs, competing endogenous RNAs (ceRNA), could possess a regulatory role, independently of their protein-coding function, by their ability to compete for microRNA binding <xref ref-type="bibr" rid="pcbi.1003455-Poliseno1">[26]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Salmena1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Poliseno2">[29]</xref>. ceRNA could act as natural microRNA sponge <xref ref-type="bibr" rid="pcbi.1003455-Ebert2">[49]</xref>. In that context, by sharing the same microRNAs, it was shown that the expression of the tumor suppressor PTEN and its pseudogene PTENP1 are positively correlated. Indeed, even if the pseudogene PTENP1 does not encode a functional protein, PTENP1 mRNA may regulate the expression of the tumor suppressor PTEN by competing for their common microRNA <xref ref-type="bibr" rid="pcbi.1003455-Tay1">[28]</xref>. It was also shown that the pseudogene PTENP1 is mutated in some cancers <xref ref-type="bibr" rid="pcbi.1003455-Tay1">[28]</xref>.</p>
<p>By resorting to our computational model linking inflammation to cell transformation, we will analyze here the regulatory role of a generic ceRNA, which could compete for the binding to Let-7 microRNA as well as the role of the pseudogene PTEN1, which competes with PTEN mRNA for the binding to miR-21 (see <xref ref-type="sec" rid="s4">Methods</xref> for more details as well as the wiring diagram in <xref ref-type="fig" rid="pcbi-1003455-g010">Fig. 10</xref>).</p>
<fig id="pcbi-1003455-g010" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g010</object-id><label>Figure 10</label><caption>
<title>Wiring diagram of the model for the epigenetic switch linking inflammation to cell transformation, including two competing endogenous RNAs (ceRNAs) (see also <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>).</title>
<p>A hypothetical ceRNA can form an inhibitory complex with Let-7 microRNA. Moreover, the addition of the messenger RNA of PTEN1, mPTEN1, which can sponge the microRNA miR-21, allows us to assess the effect of the pseudogene of PTEN (mPTEN1) on the epigenetic dynamics of cell transformation.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g010" position="float" xlink:type="simple"/></fig>
<p>Bifurcation analyzes of the steady-state levels of NF-κB, Lin28, Let-7, IL6, STAT3, and ceRNA <italic>vs</italic> Src for different rates of synthesis of ceRNA, <italic>V</italic><sub>SCERNA</sub>, suggest that a competing-endogenous RNA for the binding to Let-7 microRNA could act as an oncogene by promoting the switch to cell transformation (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s007">Fig. S7</xref>). Indeed, the model predicts that an increase in <italic>V</italic><sub>SCERNA</sub> from 0 to 1 moves the switch from a non-transformed to a transformed state to smaller levels of the inflammatory signal, Src. Furthermore, the model also shows that if the level of ceRNA is too high, i.e. <italic>V</italic><sub>SCERNA</sub> = 2, the cell is always present in a transformed state defined by high levels of NF-κB, Lin28, IL6, STAT3, and ceRNA together with a low level of Let-7.</p>
<p>By means of stochastic simulations, the model indicates that an elevated level of ceRNA decreases the robustness of the non-transformed state of the cell towards stochastic fluctuations (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s008">Fig. S8</xref>). Indeed, by increasing <italic>V</italic><sub>SCERNA</sub>, the proportion of transformed cells at low levels of Src is larger (compare <xref ref-type="supplementary-material" rid="pcbi.1003455.s008">Fig. S8B</xref>, D, F).</p>
<p>The deterministic model for a heterogeneous cell population shows that, in the absence of ceRNA, the expression levels of Let-7 and IL6 are negatively correlated with high levels of Let-7 together with low levels of IL6, which corresponds to a non-transformed state of the cell population (<xref ref-type="fig" rid="pcbi-1003455-g011">Fig. 11A</xref>). An increase in ceRNA progressively promotes the switch of the cell population to a transformed state characterized by low levels of Let-7 together with high levels of IL6 (see <xref ref-type="fig" rid="pcbi-1003455-g011">Fig. 11B, C</xref>).</p>
<fig id="pcbi-1003455-g011" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.g011</object-id><label>Figure 11</label><caption>
<title>Effect of ceRNA binding to Let-7 microRNA on the dynamics of a heterogeneous cell population.</title>
<p>Levels of expression of Let-7 <italic>vs</italic> IL6 are illustrated in a cell population without ceRNA, <italic>V</italic><sub>SCERNA</sub> = 0 in A; with a low level of ceRNA, <italic>V</italic><sub>SCERNA</sub> = 0.1 in B; and with a higher level of ceRNA, <italic>V</italic><sub>SCERNA</sub> = 0.2 in C. 100 cells are considered in the simulations with 10% of random variation from the default value on all parameters. (A) In the absence of ceRNA, the cell population is mainly in a non-transformed state characterized by high levels of Let-7 and low levels of IL6. (B) A low level of ceRNA generates a mix population of transformed and non-transformed cells. (C) In the presence of a higher level of ceRNA, nearly all cells switched to a transformed state (low levels of Let-7 together with high levels of IL6). Default parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with <italic>V</italic><sub>SLET7</sub> = 6 and Src = 0.000001. Let-7 and IL6 levels are calculated after 50 h of transient.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.g011" position="float" xlink:type="simple"/></fig>
<p>Thus, the model predicts that the effect of a ceRNA for Let-7 binding is very similar to the effect of Ras oncogene on the dynamics of the epigenetic switch leading to cell transformation.</p>
<p>Finally, the model indicates that high levels of PTEN1 mRNA delay or eventually suppress the occurrence of cell transformation (see <xref ref-type="supplementary-material" rid="pcbi.1003455.s009">Fig. S9</xref> where the time evolution of NF-κB, IL6, miR-21, and PTEN is represented for different rates of transcription of the pseudogene PTEN1, <italic>V</italic><sub>SMPTEN1</sub>). This supports the experimental observations showing that PTEN ceRNAs exhibit tumor-suppressive properties <xref ref-type="bibr" rid="pcbi.1003455-Karreth1">[50]</xref>.</p>
</sec></sec><sec id="s3">
<title>Discussion</title>
<p>Rudolf Virchow made the first connection between chronic inflammation and cancer in 1863 <xref ref-type="bibr" rid="pcbi.1003455-Balkwill1">[5]</xref>. Nowadays, molecular links between inflammation and oncogenic transformation have been established <xref ref-type="bibr" rid="pcbi.1003455-Balkwill2">[6]</xref>. However, until recently, the molecular pathways linking inflammation to cellular transformation were unknown <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. In the latter study, the authors showed that ER-Src oncoprotein by treatment with tamoxifen could convert a non-transformed cell line to a transformed state within 24–36 h. They also demonstrated that this cell transformation is mediated by an inflammatory positive feedback loop driven by NF-κB, Lin28, Let-7, and IL6 (see <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref> and <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>).</p>
<p>Based on these experiments <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>, we proposed here a computational model to account for the dynamics of the positive inflammatory feedback loop leading to cell transformation. The model includes the regulations between NF-κB, Lin28, Let-7, IL6, Ras, STAT3, miR-21, and PTEN (see <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>).</p>
<p>First the model accounts for the experimental observations showing that the non-transformed state, characterized by low levels of activators of the switch (NF-κB, Lin28, IL6, and STAT3) together with high levels of inhibitors of the switch (Let-7 and PTEN), is stable without the inflammatory signal, Src (<xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2</xref>). As in the experiments, a transient activation of Src for only 5 min triggers cell transformation within 60 h, while a constant level of Src may elicit the switch to a transformed state within 35 h (see <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2</xref>). The model also accounts for the fact that maintenance of the transformed state needs the presence of the positive feedback loop between NF-κB, Lin28, Let-7, and IL6. Indeed, a transient inhibition of NF-κB, Lin28, or IL6 abolishes the transformed state of the cell (<xref ref-type="supplementary-material" rid="pcbi.1003455.s001">Fig. S1</xref>).</p>
<p>In the model, each component is embedded at least in one positive feedback (PF) loop (see wiring diagram in <xref ref-type="fig" rid="pcbi-1003455-g001">Fig. 1</xref>). The main PF loop is based on the regulations between NF-κB, Lin28, Let-7 and IL6. The second PF loop rests on the interactions between NF-κB, Lin28, Let-7 and Ras. The third PF loop is the mutual activation between NF-κB and IL6, while the fourth PF loop is driven by the regulatory interactions between NF-κB, IL6, STAT3, miR-21, and PTEN. Each component in the network can be clustered into one of the following two groups: activators (oncogenes such as NF-κB, Lin28, Ras, IL6, STAT3 and miR-21) or inhibitors of the switch leading to cell transformation (tumor suppressors such as Let-7 and PTEN).</p>
<p>By resorting to bifurcation analyzes, we show that an irreversible bistable switch between a transformed and a non-transformed state is at the core of the dynamics of the epigenetic switch linking inflammation to cancer (see <xref ref-type="fig" rid="pcbi-1003455-g003">Figs. 3</xref>, <xref ref-type="fig" rid="pcbi-1003455-g004">4</xref>, <xref ref-type="supplementary-material" rid="pcbi.1003455.s002">S2</xref>). The model suggests that Let-7 and PTEN act as tumor suppressors by increasing the threshold of inflammatory signal, Src, at which the switch to cell transformation occurs (see <xref ref-type="fig" rid="pcbi-1003455-g003">Figs. 3</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003455.s002">S2</xref>, respectively). On the opposite, the model shows that Ras exhibits oncogenic properties by reducing the threshold of Src at which cell transformation happens (see <xref ref-type="fig" rid="pcbi-1003455-g004">Fig. 4</xref>).</p>
<p>Thus, at any moment, there is a sensitive balance in the relative levels of oncogenes and tumor suppressors that defines the state of the cell: non-transformed versus transformed.</p>
<p>The importance of stochastic gene expression and stochastic transitions has been highlighted is many different biological contexts <xref ref-type="bibr" rid="pcbi.1003455-Kaufmann1">[51]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Raj1">[52]</xref>. A study showed that a reduction of stochastic transitions could enhance cellular memory <xref ref-type="bibr" rid="pcbi.1003455-Acar1">[53]</xref>. Stochastic mechanisms have been involved in the differentiation of mature subsets of T lymphocytes <xref ref-type="bibr" rid="pcbi.1003455-Davis1">[54]</xref>. Stochastic gene fluctuations could drive the phenotype diversity in HIV-1 <xref ref-type="bibr" rid="pcbi.1003455-Weinberger1">[55]</xref>, and stochastic epigenetic variation has been proposed to be a major force of development, evolutionary adaptation and disease <xref ref-type="bibr" rid="pcbi.1003455-Feinberg1">[44]</xref>. Stochastic phenomena could also play an important role in cancer. Indeed, stochastic appearance of mammary tumors has been observed experimentally <xref ref-type="bibr" rid="pcbi.1003455-Bouchard1">[56]</xref>. A model showed that the stochastic effect due to the finite size of active stem cell population could greatly influence the dynamics of cancer evolution <xref ref-type="bibr" rid="pcbi.1003455-Dingli1">[57]</xref>. Stochastic fluctuations may also control nonheritable cell variability, which could drive the evolutionary rate of cancer progression <xref ref-type="bibr" rid="pcbi.1003455-Frank2">[58]</xref>. Finally, it was shown both theoretically and experimentally that stochastic state transitions generate phenotypic equilibrium in populations of cancer cells <xref ref-type="bibr" rid="pcbi.1003455-Gupta1">[59]</xref>.</p>
<p>Here, we show that stochastic fluctuations may be responsible for transitions between a non-transformed and a transformed state of the cell (<xref ref-type="fig" rid="pcbi-1003455-g005">Fig. 5</xref>). Furthermore, the model predicts that the tumor suppressors Let-7 and PTEN increase the robustness of the non-transformed state of the cell towards stochastic fluctuations (<xref ref-type="fig" rid="pcbi-1003455-g006">Figs. 6</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003455.s003">S3</xref>, respectively), while the oncogene Ras decreases this robustness (<xref ref-type="fig" rid="pcbi-1003455-g007">Fig. 7</xref>). Thus, besides the crucial role of multiple and successive genetic mutations in the process of cell transformation and cancer development <xref ref-type="bibr" rid="pcbi.1003455-Hanahan1">[1]</xref>, the model points out, based on experimental observations <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>, the important effect of epigenetic mechanisms and stochastic transitions on the dynamics of cell transformation.</p>
<p>The positive inflammatory feedback loop described here seems relevant in human cancers. Indeed, cancer tissues have lower levels of Let-7 and higher levels of IL6 as compared to normal tissues, and an inverse relationship is also observed in the expression pattern of Let-7 and IL6 in prostate, breast, and hepatocellular tissues <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>. Moreover, it was shown that a related microRNA inflammatory feedback loop controls hepatocellular oncogenesis <xref ref-type="bibr" rid="pcbi.1003455-Hatziapostolou2">[60]</xref>. Here, deterministic simulations of the model in a heterogeneous cell population allow accounting qualitatively for these observations by showing this negative correlation in the expression of Let-7 and IL6 (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8</xref>). The model exhibits high levels of Let-7 and low levels of IL6 in normal conditions (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8A</xref>). As suggested by the model, an increase in the level of the oncogene Ras, in the level of Lin28 or a decrease in Let-7 triggers the switch of the cell population to a transformed state (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8B–E</xref>); while, from a transformed state, an increase in the tumor suppressor PTEN allows recovering a normal, non-transformed, state of the cell population (<xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8F</xref>).</p>
<p>Here, we consider separately the two kinds of noises that can emerge in such dynamical system: ‘intrinsic’, due to molecular noise, and ‘extrinsic’, originating from cell-to-cell variability. Of course, in real, physiological conditions, these two kinds of noises combine within a cell population. Thus, a combination of both noises (intrinsic and extrinsic) may be a driving force to trigger, in a random manner, the occurrence of the switch leading to a transformed state of the cell. The latter source of noise resulting from cell-to-cell variability seems to have an important role leading to a heterogeneous activation of NF-κB under inflammatory signaling <xref ref-type="bibr" rid="pcbi.1003455-Tay2">[45]</xref>.</p>
<p>The model also accounts for the fact that miR-21 can be viewed as an oncogene. Moreover, the positive inflammatory feedback loop between NF-κB, Lin28, Let-7, and IL6 is important for the oncogenic property of miR-21 <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>. Indeed, we show, as in the experiments, that an overexpression of miR-21 elicits cell transformation, while a concomitant overexpression of miR-21 together with an inhibition of Lin28 greatly impede this transformation (<xref ref-type="fig" rid="pcbi-1003455-g009">Figs. 9</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003455.s006">S6</xref>).</p>
<p>It was recently hypothesized that messenger RNAs, transcribed pseudogenes, and long non-coding RNAs may interact with each other using microRNA response element, MREs <xref ref-type="bibr" rid="pcbi.1003455-Salmena1">[27]</xref>. It is suggested that those competing endogenous RNAs (ceRNAs) form a large regulatory network, which could play important roles in normal and pathological conditions, such as cancer or cell differentiation <xref ref-type="bibr" rid="pcbi.1003455-Salmena1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Cesana1">[61]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Ala1">[62]</xref>.</p>
<p>By using our computational model for the epigenetic switch linking inflammation to cancer, we analyzed the dynamical consequences on cell transformation of the addition of a ceRNA competing for the binding to Let-7 microRNA as well as the addition of the transcribed pseudogene PTEN1 (see wiring diagram in <xref ref-type="fig" rid="pcbi-1003455-g010">Fig. 10</xref>). The model shows that increasing the level of a ceRNA competing for Let-7 binding reduces the threshold of Src at which the switch to cell transformation occurs (<xref ref-type="supplementary-material" rid="pcbi.1003455.s007">Fig. S7</xref>). In the presence of ceRNA, the non-transformed state of the cell is also less robust towards stochastic fluctuations (<xref ref-type="supplementary-material" rid="pcbi.1003455.s008">Fig. S8</xref>). The dynamics of a heterogeneous cell population predicts that an elevated level of ceRNA leads to the switch of the cell population to a transformed state (<xref ref-type="fig" rid="pcbi-1003455-g011">Fig. 11</xref>). Thus, the model suggests that a ceRNA competing for Let-7 binding will sponge the available Let-7 microRNA, which promotes cell transformation. Such ceRNA may thus be viewed as an oncogene.</p>
<p>On the opposite, the model suggests that the addition of a ceRNA such as PTEN1 mRNA, competing with PTEN mRNA for binding to miR-21 microRNA, could act as a tumor suppressor inhibiting the occurrence of cell transformation (<xref ref-type="supplementary-material" rid="pcbi.1003455.s009">Fig. S9</xref>). This result holds with experimental observations showing the potential role of PTEN1 mRNA, or of other ceRNAs for PTEN, as tumor suppressors <xref ref-type="bibr" rid="pcbi.1003455-Poliseno1">[26]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Tay1">[28]</xref>, <xref ref-type="bibr" rid="pcbi.1003455-Karreth1">[50]</xref>.</p>
<p>In summary, the model proposed here brings to light a comprehensive qualitative picture of the dynamics of the epigenetic switch linking inflammation to cell transformation and cancer. The model predicts that bistability is at the core of the underlying mechanism driving the switch between a non-transformed and a transformed state of the cell. Activators of the switch (oncogenes) and inhibitors of the switch (tumor suppressors) regulate the occurrence of cell transformation by modulating the threshold of inflammatory signal (Src) at which the switch occurs. The model also suggests that stochastic fluctuations could be a driving force for cell transformation, and predicts that tumors suppressors and oncogenes render the non-transformed state of the cell respectively more or less robust towards stochastic fluctuations. Finally, depending on their microRNA targets, the model shows that ceRNAs may act as oncogenes or as tumor suppressors, which points out the potential role of ceRNAs in the regulation of cell transformation.</p>
</sec><sec id="s4" sec-type="methods">
<title>Methods</title>
<p>The model is described by a set of 14 kinetic equations (see first subsection below: “Kinetic equations of the model”) representing the time evolution of the concentration of the main variables driving the dynamics of the epigenetic switch linking inflammation to cell transformation. The different variables of the model are defined in <xref ref-type="table" rid="pcbi-1003455-t001">Table 1</xref>, while the description of the parameters, together with their numerical values used in the simulations, are found in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref>. The stochastic version of the model is presented in <xref ref-type="supplementary-material" rid="pcbi.1003455.s011">Table S1</xref> (see Supporting Information). It consists of a set of reactions, which are directly related to the deterministic kinetic reactions and is simulated with the Gillespie algorithm <xref ref-type="bibr" rid="pcbi.1003455-Gillespie1">[63]</xref>.</p>
<table-wrap id="pcbi-1003455-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003455.t002</object-id><label>Table 2</label><caption>
<title>Parameters of the model.</title>
</caption><alternatives><graphic id="pcbi-1003455-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003455.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"><underline>Symbol</underline></td>
<td align="left" rowspan="1" colspan="1"><underline>Definition</underline></td>
<td align="left" rowspan="1" colspan="1"><underline>Numerical value</underline></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>AA1NFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the activation of NFKB by Src</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>AA2NFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the activation of NFKB by IL6</td>
<td align="left" rowspan="1" colspan="1">0.09</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>AA3NFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the activation of NFKB by Ras</td>
<td align="left" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>IPTEN</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the inhibition of NFKB activation by PTEN</td>
<td align="left" rowspan="1" colspan="1">5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>DNFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate for NFKB inactivation</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Src</italic></td>
<td align="left" rowspan="1" colspan="1">Src kinase oncoprotein (signal triggering an inflammatory response leading to an activation of the epigenetic switch)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>ANFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the activation of NFKB</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>INFKB</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the inhibition of NFKB</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>NFKB</italic><sub>T</sub></td>
<td align="left" rowspan="1" colspan="1">Total concentration of NFKB</td>
<td align="left" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SLIN28</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate of synthesis of Lin28</td>
<td align="left" rowspan="1" colspan="1">0.012</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>A1NF</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the activation of Lin28 synthesis by NFKB</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DLIN28</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of Lin28</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SLET7</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate of synthesis of Let7 microRNA</td>
<td align="left" rowspan="1" colspan="1">3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>ILET7</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the repression of Let7 synthesis by Lin28</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>1</sub></td>
<td align="left" rowspan="1" colspan="1">Bimolecular rate constant for binding of Let7 to mIL6</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>2</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for dissociation of complex (mIL6Let7) between Let7 and mIL6</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>3</sub></td>
<td align="left" rowspan="1" colspan="1">Bimolecular rate constant for binding of Let7 to mRas</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>4</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for dissociation of complex (mRasLet7) between Let7 and mRas</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>5</sub></td>
<td align="left" rowspan="1" colspan="1">Bimolecular rate constant for binding of miR21 to mPTEN</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>6</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for dissociation of complex (miRmpten) between miR21 and mPTEN</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DLET7</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for degradation of Let7 microRNA</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>S1MIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Independent rate of synthesis of IL6 mRNA, mIL6</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>S2MIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate of synthesis of IL6 mRNA depending on NFKB</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>A2NF</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the activation of mIL6 synthesis by NFKB</td>
<td align="left" rowspan="1" colspan="1">5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of IL6 mRNA</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DILLET</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of the complex between Let7 and mIL6</td>
<td align="left" rowspan="1" colspan="1">0.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>SIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the synthesis of IL6 protein</td>
<td align="left" rowspan="1" colspan="1">1.2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of IL6 protein</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SMRAS</sub></td>
<td align="left" rowspan="1" colspan="1">Rate of synthesis of Ras mRNA, mRas</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMRAS</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of mRas</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DRASLET</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of the complex between Let7 and mRas</td>
<td align="left" rowspan="1" colspan="1">0.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>SRAS</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the synthesis of Ras protein</td>
<td align="left" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DRAS</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of Ras protein</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SSTAT</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate of synthesis of STAT3</td>
<td align="left" rowspan="1" colspan="1">0.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>AIL6</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the activation of STAT3 synthesis by IL6</td>
<td align="left" rowspan="1" colspan="1">40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DSTAT</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of STAT3</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SMIR21</sub></td>
<td align="left" rowspan="1" colspan="1">Maximum rate of synthesis of miR21 microRNA</td>
<td align="left" rowspan="1" colspan="1">4</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>K</italic><sub>ASTAT</sub></td>
<td align="left" rowspan="1" colspan="1">Michaelis constant for the activation miR21 synthesis by STAT3</td>
<td align="left" rowspan="1" colspan="1">5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMIR21</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of miR21</td>
<td align="left" rowspan="1" colspan="1">0.2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SMPTEN</sub></td>
<td align="left" rowspan="1" colspan="1">Rate of synthesis of PTEN mRNA, mPTEN</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMPTEN</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of mPTEN</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMIRMP</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of the complex between mPTEN and miR21</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>SPTEN</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the synthesis of PTEN protein</td>
<td align="left" rowspan="1" colspan="1">0.05</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DPTEN</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of PTEN protein</td>
<td align="left" rowspan="1" colspan="1">0.1</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>Addition of a competing endogenous RNA (ceRNA), which can bind to Let-7 microRNA</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SCERNA</sub></td>
<td align="left" rowspan="1" colspan="1">Rate of synthesis of ceRNA</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>7</sub></td>
<td align="left" rowspan="1" colspan="1">Bimolecular rate constant for binding of Let7 to ceRNA</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>8</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for dissociation of complex (ceRNAlet7) between Let7 and ceRNA</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DCERNA</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of ceRNA</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DCELET7</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of the complex ceRNAlet7</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>Addition of PTEN1 mRNA, which can bind to the microRNA miR-21</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>V</italic><sub>SMPTEN1</sub></td>
<td align="left" rowspan="1" colspan="1">Rate of synthesis of PTEN1 mRNA, mPTEN1</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>9</sub></td>
<td align="left" rowspan="1" colspan="1">Bimolecular rate constant for binding of mPTEN1 to miR21</td>
<td align="left" rowspan="1" colspan="1">10</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>10</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for dissociation of complex (miRmpten1) between mPTEN1 and miR21</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMPTEN1</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of mPTEN1</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>k</italic><sub>DMIRMP1</sub></td>
<td align="left" rowspan="1" colspan="1">Rate constant for the degradation of miRmpten1</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p><underline>Note</underline>: Because many of the parameters have not been determined experimentally, and since the study focuses on the dynamic implications of the regulatory structure of the epigenetic switch linking inflammation to cell transformation —i.e., its wiring diagram, or topology, which is crucial for the network behavior (see <xref ref-type="bibr" rid="pcbi.1003455-Wagner1">[65]</xref>)— the numerical values have been selected so as to yield a non-transformed state without the inflammatory signal, Src; or a transformed state within 36 h–60 h depending on the duration of the transient inflammatory signal (see <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2</xref> as well as experimental observations in Ref. <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>). The time units for the parameters in the model are expressed in minutes, while the concentrations are expressed in µM.</p></fn><fn id="nt102"><label/><p>The mechanisms of control of miRNA degradation are complex and not fully understood <xref ref-type="bibr" rid="pcbi.1003455-Zhang1">[66]</xref>. To keep the model simple, we hypothesize that each complex between a messenger RNA and its regulating miRNA is rapidly targeted for degradation.</p></fn><fn id="nt103"><label/><p>Moreover, the rates of synthesis and degradation of messenger RNAs and proteins considered in the model are in the same order of magnitude as observed experimentally in a global quantification of mammalian gene expression control <xref ref-type="bibr" rid="pcbi.1003455-Schwanhausser1">[67]</xref>.</p></fn><fn id="nt104"><label/><p>Finally, to compensate for our lack of knowledge about parameter values, we performed many bifurcation analyses, which bring to light the dynamical behaviors of the model as parameter values vary. In our experience, the dynamical properties of such models depend more on its network structure than on precise values of the parameters.</p></fn></table-wrap-foot></table-wrap>
<p>A description of the effect of a competing endogenous RNA, ceRNA, for Let-7 microRNA, as well as the effect of PTEN1 mRNA on the dynamics of the epigenetic switch can be found in subsection 2: “Effect of competing endogenous RNA, ceRNA, binding to Let-7 microRNA on the dynamics of the epigenetic switch leading to cell transformation”; and in subsection 3: “Role of PTEN1 mRNA in cell transformation”, respectively. The values for the initial conditions used in the simulations can be found in subsection 4: “Initial conditions”.</p>
<sec id="s4a">
<title>1. Kinetic equations of the model</title>
<p>In the model, we consider for simplicity a constant total concentration of NF-κB, <italic>NFKB</italic><sub>T</sub>. Activation and inactivation reactions of NF-κB behave as Goldbeter-Koshland switches <xref ref-type="bibr" rid="pcbi.1003455-Goldbeter1">[64]</xref>. All other processes of the model rest on mass-action kinetics.<disp-formula id="pcbi.1003455.e001"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e001" xlink:type="simple"/><label>(1)</label></disp-formula><disp-formula id="pcbi.1003455.e002"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e002" xlink:type="simple"/><label>(2)</label></disp-formula><disp-formula id="pcbi.1003455.e003"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e003" xlink:type="simple"/><label>(3)</label></disp-formula><disp-formula id="pcbi.1003455.e004"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e004" xlink:type="simple"/><label>(4)</label></disp-formula><disp-formula id="pcbi.1003455.e005"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e005" xlink:type="simple"/><label>(5)</label></disp-formula><disp-formula id="pcbi.1003455.e006"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e006" xlink:type="simple"/><label>(6)</label></disp-formula><disp-formula id="pcbi.1003455.e007"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e007" xlink:type="simple"/><label>(7)</label></disp-formula><disp-formula id="pcbi.1003455.e008"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e008" xlink:type="simple"/><label>(8)</label></disp-formula><disp-formula id="pcbi.1003455.e009"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e009" xlink:type="simple"/><label>(9)</label></disp-formula><disp-formula id="pcbi.1003455.e010"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e010" xlink:type="simple"/><label>(10)</label></disp-formula><disp-formula id="pcbi.1003455.e011"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e011" xlink:type="simple"/><label>(11)</label></disp-formula><disp-formula id="pcbi.1003455.e012"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e012" xlink:type="simple"/><label>(12)</label></disp-formula><disp-formula id="pcbi.1003455.e013"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e013" xlink:type="simple"/><label>(13)</label></disp-formula><disp-formula id="pcbi.1003455.e014"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e014" xlink:type="simple"/><label>(14)</label></disp-formula>With the following conservation equation:<disp-formula id="pcbi.1003455.e015"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e015" xlink:type="simple"/></disp-formula>The ‘ode’ code of the deterministic model can be found in Supporting Information (<xref ref-type="supplementary-material" rid="pcbi.1003455.s010">Model S1</xref>). Such code can be run quite easily with the program XPP/XPPAUT (<ext-link ext-link-type="uri" xlink:href="http://www.math.pitt.edu/~bard/xpp/xpp.html" xlink:type="simple">http://www.math.pitt.edu/~bard/xpp/xpp.html</ext-link>).</p>
</sec><sec id="s4b">
<title>2. Effect of competing endogenous RNA, ceRNA, binding to Let-7 microRNA on the dynamics of the epigenetic switch leading to cell transformation</title>
<p>To account for the effect of a competing endogenous RNA, ceRNA, binding to Let-7 microRNA on the dynamics of the epigenetic switch, we add two kinetic equations describing the time evolution of ceRNA (see <xref ref-type="disp-formula" rid="pcbi.1003455.e016">Eq. (15)</xref>) as well as the time evolution of the inhibitory complex between ceRNA and Let-7, ceRNAlet7 (see <xref ref-type="disp-formula" rid="pcbi.1003455.e017">Eq. (16)</xref>). Moreover, we include the terms of association and dissociation of Let-7 to ceRNA in the kinetic equation describing the time evolution of Let-7 in <xref ref-type="disp-formula" rid="pcbi.1003455.e003">Eq. (3)</xref> (see new <xref ref-type="disp-formula" rid="pcbi.1003455.e018">Eq. (3′)</xref>).<disp-formula id="pcbi.1003455.e016"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e016" xlink:type="simple"/><label>(15)</label></disp-formula><disp-formula id="pcbi.1003455.e017"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e017" xlink:type="simple"/><label>(16)</label></disp-formula><disp-formula id="pcbi.1003455.e018"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e018" xlink:type="simple"/><label>(3’)</label></disp-formula></p>
</sec><sec id="s4c">
<title>3. Role of PTEN1 mRNA in cell transformation</title>
<p>In a similar manner, to account for the effect of PTEN1 mRNA, mPTEN1, on the dynamics of the epigenetic switch, we add two kinetic equations describing the time evolution of mPTEN1 (see <xref ref-type="disp-formula" rid="pcbi.1003455.e019">Eq. (17)</xref>) as well as the time evolution of the inhibitory complex between mPTEN1 and the microRNA miR-21, miRmPTEN1 (see <xref ref-type="disp-formula" rid="pcbi.1003455.e020">Eq. (18)</xref>. Moreover, we include the terms of association and dissociation of miR-21 to mPTEN1 in the kinetic equation describing the time evolution of miR-21 in <xref ref-type="disp-formula" rid="pcbi.1003455.e011">Eq. (11)</xref> (see new <xref ref-type="disp-formula" rid="pcbi.1003455.e021">Eq. (11′)</xref>).<disp-formula id="pcbi.1003455.e019"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e019" xlink:type="simple"/><label>(17)</label></disp-formula><disp-formula id="pcbi.1003455.e020"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e020" xlink:type="simple"/><label>(18)</label></disp-formula><disp-formula id="pcbi.1003455.e021"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003455.e021" xlink:type="simple"/><label>(11’)</label></disp-formula></p>
</sec><sec id="s4d">
<title>4. Initial conditions</title>
<p>In the simulations of <xref ref-type="fig" rid="pcbi-1003455-g002">Figs. 2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003455.s001">S1</xref>, with the parameter values of <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> and with Src = 0, the following initial conditions have been chosen so as to reach a non-transformed state of the cell characterized by high levels of Let7 and PTEN together with low levels of NF-κB, Lin28, IL6 and STAT3.</p>
<p><italic>NFKB</italic> = 0.01; <italic>Lin28</italic> = 0.01; <italic>Let7</italic> = 1; <italic>mIL6</italic> = 0.01; <italic>IL6</italic> = 0.01; <italic>mRas</italic> = 0.01; <italic>Ras</italic> = 0.01; <italic>STAT3</italic> = 0.01; <italic>mPTEN</italic> = 0.01; <italic>mRasLet7</italic> = 0; <italic>mIL6Let7</italic> = 0; <italic>miR21</italic> = 0; <italic>PTEN</italic> = 0; <italic>MiRmPTEN</italic> = 0.</p>
<p>For the same conditions on the parameters, the following initial conditions have been chosen in all the other figures, giving rise to a switch at about t = 20 h.</p>
<p><italic>NFKB</italic> = 0.5; <italic>Lin28</italic> = 0.5; <italic>Let7</italic> = 1; <italic>mIL6</italic> = 0.5; <italic>IL6</italic> = 0.5; <italic>mRas</italic> = 0.5; <italic>Ras</italic> = 0.5; <italic>STAT3</italic> = 0.5; <italic>mPTEN</italic> = 0.01; <italic>mRasLet7</italic> = 0; <italic>mIL6Let7</italic> = 0; <italic>miR21</italic> = 0; <italic>PTEN</italic> = 0; <italic>MiRmPTEN</italic> = 0; CeRNA = 0; <italic>CeRNALet7</italic> = 0; <italic>mPTEN1</italic> = 0; <italic>MiRmPTEN1</italic> = 0.</p>
<p>Because the dynamics of the model for the epigenetic switch linking inflammation to cell transformation rests on an irreversible bistable switch, such dynamics will be sensitive to the value of the initial conditions of the different variables defining the system. For the same parameter values, depending on the values of the initial conditions, the system may tend to a transformed or a non-transformed state of the cell (not shown).</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1003455.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p>Importance of the positive inflammatory feedback loop to maintain the transformed state of the cell. Time evolution of NF-κB, Lin28, Let-7, IL6 and STAT3 is shown in the presence of transient inhibition of NF-κB (A), Lin28 (B), or IL6 (C). In each case, from t = 0, 5 minutes of Src signaling is sufficient to trigger cell transformation at t = 60 h (same condition as in <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2C</xref>). From 100 h&lt;t&lt;130 h, a transient inhibition of NF-κB (<italic>k</italic><sub>AA1NFKB</sub> = <italic>k</italic><sub>AA2NFKB</sub> = <italic>k</italic><sub>AA3NFKB</sub> = 0) in A, of Lin28 (<italic>V</italic><sub>SLIN28</sub> = 0) in B, or of IL6 (<italic>V</italic><sub>S1MIL6</sub> = <italic>V</italic><sub>S2MIL6</sub> = 0) in C is sufficient to abolish the transformed state and to recover a normal, non-transformed state, characterized by a high level of Let-7 together with low levels of Lin28, IL6, NF-κB and STAT3. Other parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g002">Fig. 2C</xref>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p>Effect of the tumor suppressor PTEN on the dynamical behavior of the switch linking inflammation to cell transformation. Steady-state levels of Let-7 and IL6 are represented as a function of Src in panels A and B respectively, for different rates of transcription of PTEN, <italic>V</italic><sub>SMPTEN</sub>. Solid curves: stable steady states, dashed curves: unstable states. A non-transformed state of the cell is associated with high levels of Let-7 together with low levels of IL6, while low levels of Let-7 together with high levels of IL6 characterize a transformed state. By increasing <italic>V</italic><sub>SMPTEN</sub> from 0.01 to 0.5, the threshold for cell transformation moves to higher values of Src, which might correspond to experimental observations showing the tumor-suppressive properties of PTEN (see Ref. <xref ref-type="bibr" rid="pcbi.1003455-GarciaCao1">[47]</xref>). Parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g003">Fig. 3</xref> with <italic>V</italic><sub>SLET7</sub> = 6 and <italic>V</italic><sub>SMRAS</sub> = 0.03.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p>Effect of PTEN on the robustness of the epigenetic switch towards stochastic fluctuations. Deterministic steady state levels of IL6 <italic>vs</italic> Src are shown for a low, <italic>V</italic><sub>SMPTEN</sub> = 0.01 in A, and for a high rate of synthesis of PTEN mRNA, <italic>V</italic><sub>SMPTEN</sub> = 0.05 in C. Red dots correspond to the stable steady state reached with the initial conditions used. The corresponding stochastic simulations illustrate the proportion of transformed <italic>vs</italic> non-transformed cells as a function of Src in B and D. The proportion of cells is calculated with 50 stochastic cells for each condition (see also <xref ref-type="fig" rid="pcbi-1003455-g006">Figs. 6</xref> and <xref ref-type="fig" rid="pcbi-1003455-g007">7</xref>). An increase in the level of PTEN enhances the robustness of the switch towards stochastic fluctuations by decreasing the proportion of transformed cells at low values of Src (compare B and D). Parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with <italic>V</italic><sub>SLET7</sub> = 3.5.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p>Robustness of the epigenetic switch leading to cell transformation in a heterogeneous cell population. Expression levels of Let-7 and IL6 are represented in normal, non-transformed conditions (see conditions of <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8A</xref> and panels A, D, G, J); in presence of high levels of Ras (see conditions of <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8C</xref> and panels B, E, H, K); and in the presence of high levels of Ras together with high levels of PTEN (see conditions of <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8F</xref> and panels C, F, I, L). For each case, random variation of 5% (A, B, C), 10% (D, E, F), 25% (G, H, I), and 50% (J, K, L) are applied on every parameters of the model. For each simulation, 100 cells are considered. Other parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8</xref>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s005" position="float" xlink:type="simple"><label>Figure S5</label><caption>
<p>Digital, on-off response of NF-κB in a heterogeneous cell population. Expression levels of Let-7 and NF-κB are illustrated for increasing levels of the inflammatory signal, Src. Src is equal to 0.00001 in A, 0.0001 in B, and 0.001 in C. In each condition, 25% of random variation on every parameter value of the model is applied. For each simulation, 100 cells are considered. Other conditions are as in <xref ref-type="fig" rid="pcbi-1003455-g008">Fig. 8A</xref>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s006" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s006" position="float" xlink:type="simple"><label>Figure S6</label><caption>
<p>Role of miR-21 for the dynamics of cell transformation in a heterogeneous cell population. miR-21 <italic>vs</italic> STAT3 levels as well as miR-21 <italic>vs</italic> PTEN levels are represented in the presence of a low, <italic>V</italic><sub>SMIR21</sub> = 4 in A, B, and a high rate of synthesis of miR-21, <italic>V</italic><sub>SMIR21</sub> = 4000 in C, D; as well as in the presence of a high rate of synthesis of miR-21, <italic>V</italic><sub>SMIR21</sub> = 4000, together with a low rate of synthesis of Lin28, <italic>V</italic><sub>SLIN28</sub> = 0.008 (E, F). As observed in the experiments (see Ref. <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>), the expression levels of miR-21 and STAT3 are positively correlated, while the expression levels of miR-21 and PTEN are negatively correlated. (A, B) A mixed population of non-transformed (low levels of miR-21 and STAT3 together with a high level of PTEN) and transformed cells (high levels of miR-21 and STAT3 together with a low level of PTEN) is present. (C and D) From the condition in A and B, an increase in <italic>V</italic><sub>SMIR21</sub> triggers the switch of nearly all cells in the population to a transformed state. (E and F) From condition in C and D, a reduction in the level of Lin28 destabilizes the positive inflammatory feedback loop, which brings back a large proportion of cells in the population to a non-transformed state (see also Ref. <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos2">[20]</xref>). In each case, 100 cells are considered with 10% of random variation from the default value on all parameters. Other default parameter values are as in <xref ref-type="fig" rid="pcbi-1003455-g009">Fig. 9</xref>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s007" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s007" position="float" xlink:type="simple"><label>Figure S7</label><caption>
<p>Effect of a ceRNA, which binds to Let-7 microRNA, on the dynamics of the switch leading to cell transformation. Steady-state levels of NF-κB, Lin28, Let-7, IL6, STAT3 and ceRNA as a function of the inflammatory signal, Src, are shown in panels A to F, respectively. For each case, different rates of synthesis of ceRNA, <italic>V</italic><sub>SCERNA</sub> are considered. Here again, an irreversible bistable behavior characterizes the epigenetic switch leading to cell transformation. Solid curves: stable steady states; dashed curves: unstable states. A progressive increase in <italic>V</italic><sub>SCERNA</sub> from 0 to 1 moves the threshold associated with cell transformation to smaller values of Src. When <italic>V</italic><sub>SCERNA</sub> is large (<italic>V</italic><sub>SCERNA</sub> = 2), only the transformed state of the cell persists regardless of the level of Src. Parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with <italic>V</italic><sub>SLET7</sub> = 6.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s008" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s008" position="float" xlink:type="simple"><label>Figure S8</label><caption>
<p>Effect of a ceRNA binding to Let-7 on the robustness of the epigenetic switch towards stochastic fluctuations. Deterministic steady state levels of IL6 <italic>vs</italic> Src are shown when <italic>V</italic><sub>SCERNA</sub> = 0, 0.1 and 0.15 in panels A, C and E, respectively. Red dots indicate the stable steady states reached with the initial conditions used. The corresponding stochastic simulations showing the proportion of non-transformed and transformed cells <italic>vs</italic> Src are illustrated in panels B, D and F. The proportion of cells is calculated with 50 stochastic cells for each condition. In B, the absence of ceRNA predicts a robust switch leading to cell transformation, where all cells are in a non-transformed state for a low level of Src. (D) With a low level of ceRNA, a small proportion of transformed cells is present even with a low level of Src; while with a higher level of ceRNA, the model predicts that a large proportion of cells is present in a transformed state regardless of the level of Src (F). Parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with <italic>V</italic><sub>SLET7</sub> = 6.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s009" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s009" position="float" xlink:type="simple"><label>Figure S9</label><caption>
<p>PTEN1 mRNA as a tumor suppressor (see Ref. <xref ref-type="bibr" rid="pcbi.1003455-Tay1">[28]</xref>). Time evolution of NF-κB, IL6, miR-21 and PTEN are shown in panels A to D, respectively. In each case, different rates of transcription of PTEN1 mRNA, <italic>V</italic><sub>SMPTEN1</sub> are considered. With the conditions used, an inflammatory response leading to cell transformation occurs quickly when <italic>V</italic><sub>SMPTEN1</sub> = 0 (red curve in each case). Cell transformation is characterized by the rise in the levels of NF-κB, IL6 and miR-21, while the level of PTEN decreases. A small level of PTEN1 mRNA (blue curve with <italic>V</italic><sub>SMPTEN1</sub> = 0.15) delays the occurrence of cell transformation. In the latter case, the model clearly shows the biphasic regulation of IL6 expression, as observed in the experiments (see Ref. <xref ref-type="bibr" rid="pcbi.1003455-Iliopoulos1">[7]</xref>). With larger levels of PTEN1 mRNA (green curve with <italic>V</italic><sub>SMPTEN1</sub> = 0.2 or orange curve with <italic>V</italic><sub>SMPTEN1</sub> = 0.5), the model exhibits only a transient inflammatory response (see transient peak of IL6), which does not lead to cell transformation. Parameter values are as in <xref ref-type="table" rid="pcbi-1003455-t002">Table 2</xref> with <italic>V</italic><sub>SLET7</sub> = 1.15, <italic>V</italic><sub>SMIR21</sub> = 10, <italic>K</italic><sub>IPTEN</sub> = 0.1, <italic>V</italic><sub>SMPTEN</sub> = 3, and <italic>k</italic><sub>SPTEN</sub> = 0.3.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s010" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s010" position="float" xlink:type="simple"><label>Model S1</label><caption>
<p>Code for the deterministic version of the model linking inflammation to cell transformation, which can be run with the program XPP/XPPAUT (<ext-link ext-link-type="uri" xlink:href="http://www.math.pitt.edu/~bard/xpp/xpp.html" xlink:type="simple">http://www.math.pitt.edu/~bard/xpp/xpp.html</ext-link>).</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003455.s011" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pcbi.1003455.s011" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Stochastic version of the model linking inflammation to cell transformation.</p>
<p>(DOCX)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pcbi.1003455-Hanahan1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hanahan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>RA</given-names></name> (<year>2011</year>) <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source> <volume>144</volume>: <fpage>646</fpage>–<lpage>674</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Chiba1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chiba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Marusawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ushijima</surname><given-names>T</given-names></name> (<year>2012</year>) <article-title>Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation</article-title>. <source>Gastroenterology</source> <volume>143</volume>: <fpage>550</fpage>–<lpage>563</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Sun1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Karin</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Obesity, inflammation, and liver cancer</article-title>. <source>J Hepatol</source> <volume>56</volume>: <fpage>704</fpage>–<lpage>713</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Martin1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Herceg</surname><given-names>Z</given-names></name> (<year>2012</year>) <article-title>From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms</article-title>. <source>Genome Med</source> <volume>4</volume>: <fpage>8</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Balkwill1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balkwill</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>Inflammation and cancer: back to Virchow?</article-title> <source>Lancet</source> <volume>357</volume>: <fpage>539</fpage>–<lpage>545</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Balkwill2"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balkwill</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Coussens</surname><given-names>LM</given-names></name> (<year>2004</year>) <article-title>Cancer: an inflammatory link</article-title>. <source>Nature</source> <volume>431</volume>: <fpage>405</fpage>–<lpage>406</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Iliopoulos1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iliopoulos</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hirsch</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Struhl</surname><given-names>K</given-names></name> (<year>2009</year>) <article-title>An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation</article-title>. <source>Cell</source> <volume>139</volume>: <fpage>693</fpage>–<lpage>706</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Carthew1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carthew</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Sontheimer</surname><given-names>EJ</given-names></name> (<year>2009</year>) <article-title>Origins and Mechanisms of miRNAs and siRNAs</article-title>. <source>Cell</source> <volume>136</volume>: <fpage>642</fpage>–<lpage>655</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Mukherji1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mukherji</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>GX</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>PA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>MicroRNAs can generate thresholds in target gene expression</article-title>. <source>Nat Genet</source> <volume>43</volume>: <fpage>854</fpage>–<lpage>859</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Selbach1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Selbach</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schwanhausser</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Thierfelder</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Khanin</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Widespread changes in protein synthesis induced by microRNAs</article-title>. <source>Nature</source> <volume>455</volume>: <fpage>58</fpage>–<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Tsang1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van Oudenaarden</surname><given-names>A</given-names></name> (<year>2007</year>) <article-title>MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals</article-title>. <source>Mol Cell</source> <volume>26</volume>: <fpage>753</fpage>–<lpage>767</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Herranz1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herranz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>SM</given-names></name> (<year>2010</year>) <article-title>MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems</article-title>. <source>Genes Dev</source> <volume>24</volume>: <fpage>1339</fpage>–<lpage>1344</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Osella1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Osella</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bosia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cora</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Caselle</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>The role of incoherent microRNA-mediated feedforward loops in noise buffering</article-title>. <source>PLoS Comput Biol</source> <volume>7</volume>: <fpage>e1001101</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Ebert1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ebert</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>PA</given-names></name> (<year>2012</year>) <article-title>Roles for microRNAs in conferring robustness to biological processes</article-title>. <source>Cell</source> <volume>149</volume>: <fpage>515</fpage>–<lpage>524</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Laudadio1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laudadio</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Manfroid</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Achouri</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>MD</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation</article-title>. <source>Gastroenterology</source> <volume>142</volume>: <fpage>119</fpage>–<lpage>129</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Barh1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Malhotra</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ravi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sindhurani</surname><given-names>P</given-names></name> (<year>2010</year>) <article-title>MicroRNA let-7: an emerging next-generation cancer therapeutic</article-title>. <source>Curr Oncol</source> <volume>17</volume>: <fpage>70</fpage>–<lpage>80</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Kumar1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Erkeland</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Pester</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Suppression of non-small cell lung tumor development by the let-7 microRNA family</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>: <fpage>3903</fpage>–<lpage>3908</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Peter1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peter</surname><given-names>ME</given-names></name> (<year>2009</year>) <article-title>Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression</article-title>. <source>Cell Cycle</source> <volume>8</volume>: <fpage>843</fpage>–<lpage>852</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Ventura1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ventura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jacks</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>MicroRNAs and cancer: short RNAs go a long way</article-title>. <source>Cell</source> <volume>136</volume>: <fpage>586</fpage>–<lpage>591</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Iliopoulos2"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iliopoulos</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jaeger</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Hirsch</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Bulyk</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Struhl</surname><given-names>K</given-names></name> (<year>2010</year>) <article-title>STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer</article-title>. <source>Mol Cell</source> <volume>39</volume>: <fpage>493</fpage>–<lpage>506</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Mathews1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mathews</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Crea</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Farrar</surname><given-names>WL</given-names></name> (<year>2009</year>) <article-title>Epigenetic gene regulation in stem cells and correlation to cancer</article-title>. <source>Differentiation</source> <volume>78</volume>: <fpage>1</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Munoz1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munoz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Iliou</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Esteller</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Epigenetic alterations involved in cancer stem cell reprogramming</article-title>. <source>Mol Oncol</source> <volume>6</volume>: <fpage>620</fpage>–<lpage>636</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Hatziapostolou1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hatziapostolou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Iliopoulos</surname><given-names>D</given-names></name> (<year>2011</year>) <article-title>Epigenetic aberrations during oncogenesis</article-title>. <source>Cell Mol Life Sci</source> <volume>68</volume>: <fpage>1681</fpage>–<lpage>1702</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Vincent1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vincent</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Van Seuningen</surname><given-names>I</given-names></name> (<year>2012</year>) <article-title>On the epigenetic origin of cancer stem cells</article-title>. <source>Biochim Biophys Acta</source> <volume>1826</volume>: <fpage>83</fpage>–<lpage>88</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Goldberg1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldberg</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Allis</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Bernstein</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>Epigenetics: a landscape takes shape</article-title>. <source>Cell</source> <volume>128</volume>: <fpage>635</fpage>–<lpage>638</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Poliseno1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poliseno</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Carver</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Haveman</surname><given-names>WJ</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A coding-independent function of gene and pseudogene mRNAs regulates tumour biology</article-title>. <source>Nature</source> <volume>465</volume>: <fpage>1033</fpage>–<lpage>1038</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Salmena1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Poliseno</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tay</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kats</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pandolfi</surname><given-names>PP</given-names></name> (<year>2011</year>) <article-title>A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?</article-title> <source>Cell</source> <volume>146</volume>: <fpage>353</fpage>–<lpage>358</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Tay1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tay</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kats</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Salmena</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs</article-title>. <source>Cell</source> <volume>147</volume>: <fpage>344</fpage>–<lpage>357</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Poliseno2"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poliseno</surname><given-names>L</given-names></name> (<year>2012</year>) <article-title>Pseudogenes: newly discovered players in human cancer</article-title>. <source>Sci Signal</source> <volume>5</volume>: <fpage>re5</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Gao1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gao</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lafdil</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>D</given-names></name> (<year>2012</year>) <article-title>STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver</article-title>. <source>J Hepatol</source> <volume>57</volume>: <fpage>430</fpage>–<lpage>441</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Loffler1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Loffler</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Brocke-Heidrich</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pfeifer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stocsits</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hackermuller</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer</article-title>. <source>Blood</source> <volume>110</volume>: <fpage>1330</fpage>–<lpage>1333</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Niu1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Haura</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis</article-title>. <source>Oncogene</source> <volume>21</volume>: <fpage>2000</fpage>–<lpage>2008</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Yu1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pardoll</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jove</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>STATs in cancer inflammation and immunity: a leading role for STAT3</article-title>. <source>Nat Rev Cancer</source> <volume>9</volume>: <fpage>798</fpage>–<lpage>809</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Frank1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frank</surname><given-names>DA</given-names></name> (<year>2007</year>) <article-title>STAT3 as a central mediator of neoplastic cellular transformation</article-title>. <source>Cancer Lett</source> <volume>251</volume>: <fpage>199</fpage>–<lpage>210</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Bromberg1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bromberg</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Wrzeszczynska</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Devgan</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pestell</surname><given-names>RG</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Stat3 as an oncogene</article-title>. <source>Cell</source> <volume>98</volume>: <fpage>295</fpage>–<lpage>303</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Garcia1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garcia</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Alaniz</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Cordo Russo</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Alvarez</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hajos</surname><given-names>SE</given-names></name> (<year>2009</year>) <article-title>PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines</article-title>. <source>Leuk Res</source> <volume>33</volume>: <fpage>288</fpage>–<lpage>296</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Guigon1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guigon</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Willingham</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>SY</given-names></name> (<year>2009</year>) <article-title>PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer</article-title>. <source>Oncogene</source> <volume>28</volume>: <fpage>509</fpage>–<lpage>517</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Hoffmann1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Levchenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>2002</year>) <article-title>The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation</article-title>. <source>Science</source> <volume>298</volume>: <fpage>1241</fpage>–<lpage>1245</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Kearns1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kearns</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Basak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Werner</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression</article-title>. <source>J Cell Biol</source> <volume>173</volume>: <fpage>659</fpage>–<lpage>664</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Ashall1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashall</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>CV</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription</article-title>. <source>Science</source> <volume>324</volume>: <fpage>242</fpage>–<lpage>246</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Rao1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rao</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hayden</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>West</surname><given-names>AP</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response</article-title>. <source>Nature</source> <volume>466</volume>: <fpage>1115</fpage>–<lpage>1119</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Basak1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Basak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Behar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>A</given-names></name> (<year>2012</year>) <article-title>Lessons from mathematically modeling the NF-kappaB pathway</article-title>. <source>Immunol Rev</source> <volume>246</volume>: <fpage>221</fpage>–<lpage>238</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Shields1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shields</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Desgrosellier</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Mielgo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>SK</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Oncogenic Ras/Src cooperativity in pancreatic neoplasia</article-title>. <source>Oncogene</source> <volume>30</volume>: <fpage>2123</fpage>–<lpage>2134</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Feinberg1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feinberg</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Irizarry</surname><given-names>RA</given-names></name> (<year>2010</year>) <article-title>Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>107 Suppl 1</volume>: <fpage>1757</fpage>–<lpage>1764</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Tay2"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hughey</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Lipniacki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Quake</surname><given-names>SR</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing</article-title>. <source>Nature</source> <volume>466</volume>: <fpage>267</fpage>–<lpage>271</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Turner1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Paszek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Woodcock</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Physiological levels of TNFalpha stimulation induce stochastic dynamics of NF-kappaB responses in single living cells</article-title>. <source>J Cell Sci</source> <volume>123</volume>: <fpage>2834</fpage>–<lpage>2843</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-GarciaCao1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garcia-Cao</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Hobbs</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Laurent</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Giorgi</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Systemic elevation of PTEN induces a tumor-suppressive metabolic state</article-title>. <source>Cell</source> <volume>149</volume>: <fpage>49</fpage>–<lpage>62</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Giovannetti1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giovannetti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Funel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Del Chiaro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Erozenci</surname><given-names>LA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity</article-title>. <source>Cancer Res</source> <volume>70</volume>: <fpage>4528</fpage>–<lpage>4538</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Ebert2"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ebert</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>PA</given-names></name> (<year>2010</year>) <article-title>Emerging roles for natural microRNA sponges</article-title>. <source>Curr Biol</source> <volume>20</volume>: <fpage>R858</fpage>–<lpage>861</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Karreth1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karreth</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Tay</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Perna</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ala</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma</article-title>. <source>Cell</source> <volume>147</volume>: <fpage>382</fpage>–<lpage>395</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Kaufmann1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaufmann</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Mettetal</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>van Oudenaarden</surname><given-names>A</given-names></name> (<year>2007</year>) <article-title>Heritable stochastic switching revealed by single-cell genealogy</article-title>. <source>PLoS Biol</source> <volume>5</volume>: <fpage>e239</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Raj1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van Oudenaarden</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Nature, nurture, or chance: stochastic gene expression and its consequences</article-title>. <source>Cell</source> <volume>135</volume>: <fpage>216</fpage>–<lpage>226</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Acar1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Acar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Becskei</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van Oudenaarden</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Enhancement of cellular memory by reducing stochastic transitions</article-title>. <source>Nature</source> <volume>435</volume>: <fpage>228</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Davis1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Killeen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Crooks</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Raulet</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name> (<year>1993</year>) <article-title>Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes</article-title>. <source>Cell</source> <volume>73</volume>: <fpage>237</fpage>–<lpage>247</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Weinberger1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weinberger</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Burnett</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Toettcher</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Arkin</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Schaffer</surname><given-names>DV</given-names></name> (<year>2005</year>) <article-title>Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity</article-title>. <source>Cell</source> <volume>122</volume>: <fpage>169</fpage>–<lpage>182</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Bouchard1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bouchard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lamarre</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tremblay</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Jolicoeur</surname><given-names>P</given-names></name> (<year>1989</year>) <article-title>Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene</article-title>. <source>Cell</source> <volume>57</volume>: <fpage>931</fpage>–<lpage>936</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Dingli1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dingli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Traulsen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pacheco</surname><given-names>JM</given-names></name> (<year>2007</year>) <article-title>Stochastic dynamics of hematopoietic tumor stem cells</article-title>. <source>Cell Cycle</source> <volume>6</volume>: <fpage>461</fpage>–<lpage>466</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Frank2"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frank</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Rosner</surname><given-names>MR</given-names></name> (<year>2012</year>) <article-title>Nonheritable cellular variability accelerates the evolutionary processes of cancer</article-title>. <source>PLoS Biol</source> <volume>10</volume>: <fpage>e1001296</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Gupta1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gupta</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Fillmore</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shapira</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells</article-title>. <source>Cell</source> <volume>146</volume>: <fpage>633</fpage>–<lpage>644</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Hatziapostolou2"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hatziapostolou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Polytarchou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aggelidou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Drakaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Poultsides</surname><given-names>GA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis</article-title>. <source>Cell</source> <volume>147</volume>: <fpage>1233</fpage>–<lpage>1247</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Cesana1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cesana</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cacchiarelli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Legnini</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Santini</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sthandier</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA</article-title>. <source>Cell</source> <volume>147</volume>: <fpage>358</fpage>–<lpage>369</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Ala1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ala</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Karreth</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Bosia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pagnani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Taulli</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>110</volume>: <fpage>7154</fpage>–<lpage>7159</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Gillespie1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillespie</surname><given-names>DT</given-names></name> (<year>1977</year>) <article-title>Exact Stochastic Simulation of Coupled Chemical-Reactions</article-title>. <source>Journal of Physical Chemistry</source> <volume>81</volume>: <fpage>2340</fpage>–<lpage>2361</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Goldbeter1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Koshland</surname><given-names>DE</given-names><suffix>Jr</suffix></name> (<year>1981</year>) <article-title>An amplified sensitivity arising from covalent modification in biological systems</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>78</volume>: <fpage>6840</fpage>–<lpage>6844</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Wagner1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wagner</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Circuit topology and the evolution of robustness in two-gene circadian oscillators</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>102</volume>: <fpage>11775</fpage>–<lpage>11780</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Zhang1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Brewer</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jing</surname><given-names>Q</given-names></name> (<year>2012</year>) <article-title>MicroRNA degradation and turnover: regulating the regulators</article-title>. <source>Wiley Interdiscip Rev RNA</source> <volume>3</volume>: <fpage>593</fpage>–<lpage>600</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003455-Schwanhausser1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwanhausser</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Busse</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dittmar</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schuchhardt</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Global quantification of mammalian gene expression control</article-title>. <source>Nature</source> <volume>473</volume>: <fpage>337</fpage>–<lpage>342</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>